Note: Descriptions are shown in the official language in which they were submitted.
CA 2771071 2017-03-02
WO 2011/017093
PCT/US2010/043369
ALPHA-AMYLASE BLEND FOR STARCH PROCESSING
AND METHOD OF USE THEREOF
PRIORITY
[0001] The present application claims priority to U.S. Provisional Application
Serial No.
61/232,276 filed on August 7, 2009.
FIELD OF THE INVENTION
[0003] Described herein is a method of processing a starch by contacting a low
pH,
thermostable alpha-amylase and a Bacillus lichenifortnis alpha-amylase to a
starch
substrate to liquefy the starch. The enzymes may be added as a blend or in
sequence.
The enzyme blend described herein is suitable for starch liquefaction and
saccharification,
ethanol production, and/or sweetener production, among other things. Also
described is a
method of processing starch by using the low pH, thermostable alpha-amylase
and the
Bacillus licheniformis alpha-amylase to liquefy the starch.
BACKGROUND
[0004] Starches from grain, cereals, and tubers, e.g., cornstarch, are widely
used in the
industrial manufacture of products such as sugar syrups and biofuels, For
example, high
fructose corn syrup (HFCS) is a processed form of corn glucose syrup having
high
fructose content and a sweetness comparable to sucrose, making HFCS useful as
a sugar
substitute in soft drinks and other processed foods. HFCS production currently
represents
a billion dollar industry. Similarly, the production of ethanol from starches
is a rapidly
expanding industry.
1
CA 02771071 2012-02-06
WO 2011/017093
PCT/US2010/043369
[0005] Syrups and biofuels can be produced from starch by an enzymatic process
that
catalyzes the breakdown of starch into glucose. This enzymatic process
typically
involves a sequence of enzyme-catalyzed reactions:
[0006] (1) Liquefaction: Alpha-amylases (EC 3.2.1.1) first catalyze the
degradation of a
starch suspension, which may contain 30-40% w/w dry solids (ds), to
maltodextrans.
Alpha-amylases are endohydrolases that catalyze the random cleavage of
internal a-1,
4-D-glucosidic bonds. Because liquefaction typically is conducted at high
temperatures,
e.g., 90-100 C, thermostable alpha-amylases, such as alpha-amylases from
Bacillus sp.,
are preferred for this step. Alpha-amylases currently used for this step,
e.g.,
alpha-amylases from B. licheniformis, B. amyloliquefaciens, and Geobacillus
stearothermophilus (AmyS), do not produce significant amounts of glucose.
Instead, the
resulting liquefact has a low dextrose equivalent (DE), containing maltose and
sugars
with high degrees of polymerization (DPn).
[0007] (2) Saccharification: Glucoamylases catalyze the hydrolysis of alpha-1,
4-glucosidic
linkages of maltodextrins formed after liquefaction from non-reducing ends,
releasing
D-glucose. Saccharification produces high glucose syrup. Debranching enzymes,
such as
pullulanases, can aid saccharification.
[0008] (3) Further processing: A branch point in the process occurs after the
production of
a glucose-rich syrup. If the final desired product is a biofuel, yeast can
ferment the
glucose-rich syrup to ethanol. On the other hand, if the final desired product
is a fructose-
rich syrup, glucose isomerase can catalyze the conversion of the glucose-rich
syrup to
fructose.
CA 02771071 2012-02-06
WO 2011/017093
PCT/US2010/043369
Starch granules
I35% in cold water
¨pH 6.5
40 ppm Ca2+
Starch slurry
bacterial a-amylase
Gelatinization 1 105 C, 5 min
Gelatinized starch
Liquefaction 1 95 C, 2 h
________________________________________ Liquefied starch
0.3 % 0-glucose
2.0 % maltose
97.7 % oligosaccharides
Saccharification --pH 4.5 ¨pH 5.5
glucoamylase and/or maltogenic a-amylase
pullulanase 50 ppm Ca2+
¨60 C, 72 h ¨55 C, 48 h
Glucose syrup Maltose syrup
97 % 0-glucose 4 % 0-glucose
1.5 % maltose 56 % maltose
0.5 % isomaltose 28 % maltotriose
1.0 % other oligosaccharides 12 % other olidosaccharides
[0009] Alpha-amylases are isolated from a wide variety of bacterial, fungal,
plant, and
animal sources. Many industrially important alpha-amylases are isolated from
Bacillus
sp., in part because of the generally high capacity of Bacillus to secrete
amylases into the
growth medium. In addition, Bacillus alpha-amylase variants with altered while
more
desirable properties are obtained through genetic engineering. Furthermore,
there is a
need for blends of alpha-amylases, or variants thereof, which can capitalize
on the best
properties of at least two alpha-amylases of different origins.
[0010] The Fuelzyme0-LF alpha-amylase (SEQ ID NO: 2)(Verenium Corp.) is an
engineered alpha-amylase obtained through DNA shuffling of three parental
enzymes.
See Richardson et al., .1. Biol. Chem. 277: 26501-26507 (2002); 'LS. Patent
No.:
7,323,336. The advantageous properties of the Fuelzyme -LF alpha-amylase
include:
effective viscosity reduction at a lower dose, improved thermostability, and
broad pH
operating ranges. The use of this alpha-amylase, however, is currently limited
to biofuel
applications, e.g., ethanol production, because it results in ineffectual
glucose syrup that
3
CA 02771071 2012-02-06
WO 2011/017093
PCT/US2010/043369
is not suitable for downstream applications such as sweetener applications.
Specifically,
saccharification of starch liquefact from Fuelzyme(i)-LF alpha-amylase results
in iodine-
positive saccharide (IPS), which indicates incomplete starch hydrolysis. Thus,
if a way
could be found to fully exploit the advantages of the Fuelzyme(i)-LF alpha-
amylase in
starch processing, particularly in sweetener applications, by using an
optimized blend of
alpha-amylases, this would also represent a useful contribution to the art.
SUMMARY
[0011] Starch processing for high glucose syrup production by a low pH,
thermostable
alpha-amylase, e.g., Fuelzyme(D-LF alpha-amylase, is unsatisfactory due to
ineffectual
starch hydrolysis. The present disclosure provides an enzyme blend comprising
the low
pH, thermostable alpha-amylase, e.g., Fuelzyme(D-LF alpha-amylase, and a
Bacillus
lichenifonnis alpha-amylase. When used in starch processing, the enzyme blend
eliminates iodine-positive saccharide (IPS; blue saccharide) resulted from
using the low
pH, thermostable alpha-amylase alone. Therefore, the enzyme blend produces
saccharified starch suitable for downstream applications, such as sweetener
production.
[0012] The enzyme blend for processing a starch as contemplated herein
comprises a low pH,
thermostable alpha-amylase, e.g., Fuelzyme -LF alpha-amylase, and a Bacillus
licheniformis alpha-amylase. The low pH, thermostable alpha-amylase has an
amino acid
sequence that is at least about 80%, about 85%, about 90%, about 95%, about
98%, or
about 99% identical to SEQ ID NO: 2. The enzyme blend contains at least about
0.5,
about 1.0, about 1.1, about 1.2, about 1.3, about 1.4, about 1.5, about 1.6,
about 1.7, about
1.8, about 1.9, about 2.0, about 2.5, about 3.0, about 3.5, about 4.0, about
4.5, or about 5.0
Liquefon Units (LUs) of the B. lichenifortnis alpha-amylase for every 5.0
Modified
Wohlgemuth Units (MWUs) of the low pII, thermostable alpha-amylase. At least
one
alpha-amylase of the enzyme blend may be purified. Optionally, the enzyme
blend may
further comprise a phytase.
[0013] In one aspect, disclosed is a method of processing a starch or grain,
comprising
contacting the enzyme blend to a starch and liquefying the starch to form a
liquefact. In
another aspect, disclosed is a method of processing a starch by contacting the
low pH,
4
CA 02771071 2012-02-06
WO 2011/017093
PCT/US2010/043369
thermostable alpha-amylase and the B. lichenifonnis alpha-amylase,
simultaneously or
sequentially, to a starch and liquefying the starch to form a liquefact.
During liquefying
the starch, the B. licheniformis alpha-amylase is used at an amount of about
0.5, about
1.0, about 1.1, about 1.2, about 1.3, about 1.4, about 1.5, about 1.6, about
1.7, about 1.8,
about 1.9, about 2.0, about 2.5, about 3.0, about 3.5, about 4.0, about 4.5,
or about 5.0
Liquefon Units (LUs) for every 5.0 Modified Wohlgemuth Units (MWUs) of the low
pH,
thermostable alpha-amylase per gram of dry solid starch (/g DS). The
liquefaction results
in a liquefact having a DE value of at least about 10, about 11, about 12,
about 13, about
14, about 15, about 16, about 17, about 18, about 19, or about 20 within about
90 minutes,
about 95 minutes, or about 100 minutes. The starch may be liquefied at about
80 C to
about 95 C, about 85 C to about 95 C, or about 88 C to about 92 C. The starch
may be
liquefied at about pH 5.0 to about pH 6.0, pH 5.2 to about ph 5.8, or
optionally about pH
5.6.
[0014] The B. licheniformis alpha-amylase has an amino acid sequence that is
at least about
70%, about 75%, about 80%, about 85%, about 90%, about 95%, about 98%, or
about
99% identical to SEQ ID NO: 4. The B. licheniformis alpha-amylase may comprise
an
amino acid sequence of SEQ ID NO: 6. The B. licheniformis alpha-amylase may
consist
of an amino acid sequence of SEQ Ill NO: 6. The B. licheniformis alpha-amylase
may be
a variant having one or more altered properties compared to the B.
licheniformis alpha-
amylase having a amino acid sequence of SEQ ID NO: 4. The altered properties
may
include substrate specificity, substrate binding, substrate cleavage pattern,
thermal
stability, pH activity profile, pH stability profile, stability towards
oxidation, stability at
lower levers of calcium ion (Ca2+), specific activity, or any combination
thereof. The low
pH, thermostable alpha-amylase of the disclosed enzyme blend may comprise an
amino
acid sequence of SEQ ID NO: 2. Alternatively, the low pH, thermostable alpha-
amylase
of the disclosed enzyme blend may consist of an amino acid sequence of SEQ ID
NO: 2.
[0015] Also contemplated is a method of processing a starch or grain further
comprising
saccharifying the liquefact to generate a saccharide syrup. The saccharide
syrup may
contain at least about 90%, about 91%, about 92%, about 93%,about 94%, or
about 95%
glucose at the end of saccharification. The saccharide syrup may contain less
than about
1.5%, about 1.0%, or about 0.5% v/v sediment. Moreover, the saccharified
starch may
5
CA 02771071 2012-02-06
WO 2011/017093
PCT/US2010/043369
have a filtration rate at least about 67 g/15 minutes, about 75 g/15 minutes,
about 80 g/15
minutes, about 85 g/15 minutes, or about 90 g/15 minutes.
[0016] Another contemplated aspect is a method of processing a starch or grain
further
comprising producing a high fructose syrup from the saccharide syrup. The high
fructose
syrup may be produced by contacting a glucose isomerase to the saccharide
syrup. The
glucose isomerase may be immobilized on a solid support.
BRIEF DESCRIPTION OF THE DRAWINGS
[0017] FIG. 1 depicts the results of iodine test performed with saccharified
starch
substrates from liquefact samples catalyzed by (1) 50 MWUs Fuelzyme -LF/g ds
starch
at pH 4.5, (2) 50 MWUs Fuelzyme -LF /g ds starch at pH 5.6, (3) 25 MWUs
Fuelzyme -LF /g ds starch at pII 5.6, (4) 10 LUs SPEZYME FRED (Danisco US
Inc.,
Genencor Division) /g ds starch at pH 5.8, and (5) 25 MWUs Fuelzyme -LF /g ds
starch
supplemented with 5 LUs SPEZYME0 FRED /g ds starch at pH 5.6.
DETAILED DESCRIPTION
[0018] An enzyme blend of a low pH, thermostable alpha-amylase and a Bacillus
licheniformis alpha-amylase is provided. The enzyme blend contains about 0.5,
about
1.0, about 1.1, about 1.2, about 1.3, about 1.4, about 1.5, about 1.6, about
1.7, about 1.8,
about 1.9, about 2.0, about 2.5, about 3.0, about 3.5, about 4.0, about 4.5,
or about 5.0
Liquefon Units (LUs) of the B. lichenifonnis alpha-amylase for every 5.0
Modified
Wohlgemuth Units (MWUs) of the low pH, thermostable alpha-amylase. The enzyme
blend is suitable for liquefying starch and further downstream applications of
starch
processing, e.g., sweetener applications. Also provided is a method of
processing a starch
by contacting the low pH, thermostable alpha-amylase and the Bacillus
licheniformis
alpha-amylase to the starch and liquefying the starch to form a liquefact.
During
liquefying the starch, the amount of the B. licheniforrnis alpha-amylase is
about 0.5, about
1.0, about 1.1, about 1.2, about 1.3, about 1.4, about 1.5, about 1.6, about
1.7, about 1.8,
about 1.9, about 2.0, about 2.5, about 3.0, about 3.5, about 4.0, about 4.5,
or about 5.0
6
CA 2771071 2017-03-02
WO 2011/017093
PCT/US2010/043369
Liquefon Units (LUs) for every 5.0 Modified Wohlgemuth Units (MWUs) of the low
pH,
therniostable alpha-amylase.
1. Definitions & Abbreviations
1.1. Definitions
[0019] As used herein, "starch" refers to any material comprised of the
complex
polysaccharide carbohydrates of plants, comprised of amylose and amylopectin
with the
formula (C6H1005)., wherein X can be any number. In particular, the term
refers to any
plant-based material including but not limited to grains, grasses, tubers, and
roots and
more specifically wheat, barley, corn, rye, oats, sorgum, milo, rice, sorghum,
brans,
cassava, millet, potato, sweet potato, and tapioca.
[0020] "Alpha-amylase" (e.g., E.C. 3.2.1.1) generally refers to enzymes that
catalyze the
hydrolysis of alpha-1, 4-glucosidic linkages. These enzymes have also been
described as
those effecting the exo- or endohydrolysis of 1, 4-a-D-glucosidic linkages in
polysaccharides containing 1, 4-a-linked D-glucose units. For the purpose of
the present
disclosure, "alpha-amylases" refers to those enzymes having relatively high
thermostability, i.e., with sustained activity at higher temperatures, e.g.,
above 80 C.
Accordingly, alpha-amylases are capable of liquefying starch, which is
performed at a
temperature above 80 C.
[0021] "Alpha-amylase unit" (AAU) refers to alpha-amylase activity measured
according to
the method disclosed in U.S. Patent No. 5,958,739.
One unit of AAU refers to the amount of enzyme required to hydrolyze 10 mg
of starch per minute under specified conditions. The assay for alpha-amylase
activity
uses p-nitrophenyl maltoheptoside (PNP-G7) as the substrate with the non-
reducing
terminal sugar chemically blocked. PNP- G7 can be cleaved by an endo-amylase,
for
example alpha-amylase. Following the cleavage, an alpha-glucosidase and a
glucoamylase digest the substrate to liberate free PNP molecules, which
display a yellow
color and can be measured by visible spectophometry at 410 nm. The rate of PNP
release
is proportional to alpha-amylase activity. The AAU of a given sample is
calculated
against a standard control.
7
CA 02771071 2012-02-06
WO 2011/017093
PCT/US2010/043369
[0022] As used herein, "Liquefon unit" (LU) refers to the digestion time
required to produce
a color change with iodine solution, indicating a definite stage of
dextrinization of starch
substrate under standard assay conditions. In brief, the substrate can be
soluble Lintner
starch 5 g/L in phosphate buffer, pH 6.2 (42.5 gaiter potassium dihydrogen
phosphate,
3.16 g/liter sodium hydroxide). The sample is added in 25 mM calcium chloride
and
activity is measured as the time taken to give a negative iodine test upon
incubation at
30 C. Activity is recorded in liquefons per gram or mL (LU) calculated
according to the
formula:
LU I mL or LU I g = ¨570xD
V xt
[0023] Where LU = liquefon unit; V = volume of sample (5 mL); t =
dextrinization time
(minutes); D = dilution factor = dilution volume/mL or g of added enzyme.
[0024] One "Modified Wohlgemuth unit" (MWU) refers to the amount of enzyme,
e.g.,
Fuelzyine -LF, which is able to hydrolyze 1 mg of soluble starch to specific
dextrins
under standard reaction conditions in 30 minutes. See also Diversa Corp., I
JRL at
>>http://www.diversa.com/pdf/Fuelzyme-LF_Brochure.pdf.<<
[0025] As used herein, an enzyme "blend- refers to a mixture comprising at
least two
enzymes, for example, two alpha-amylases.
[0026] "Pullulanase" refers to an amylolytic endoenzyme, capable of catalyzing
the
hydrolysis of the a-1, 6-glucosidic bonds. Pullulanases are able to degrade
pullulan,
which is regarded as a chain of maltotriose units linked by a-1, 6-glucosidic
bonds.
Pullulanases are also called debranching enzymes (E.C. 3.2.1.41; pullulan 6-
glucanohydrolase) capable of hydrolyzing a-1, 6-glucosidic linkage in an
amylopectin
95 molecule. These enzymes are generally secreted by Bacillus species,
e.g., Bacillus
clemmificans (U.S. Patent No. 5,817,498), Bacillus acidopullulyticus (European
Patent
Application No. 82302001.1 (Publication No. 0063909)), and Bacillus
naganoensis (U.S.
Patent No. 5,055,403). Commercially available enzymes having pullulanase
activity
8
CA 02771071 2012-02-06
WO 2011/017093
PCT/US2010/043369
include, for example, OPTIMAX L-1000 (Danisco US Inc., Genencor Division) and
Promozyme (Novozymes A/S).
[0027] As used herein, "iodine-positive saccharide" (IPS), used
interchangeably with "starch-
positive saccharide" or "blue saccharide," refers to saccharification liquor
containing
amylose that is not hydrolyzed after liquefaction and saccharification. When
saccharified
starch is tested with iodine, the high DPn amylose binds iodine and produces a
characteristic blue color. IPS is highly undesirable in starch processing
application,
particularly in sweetener applications. Specifically, IPS indicates poor
liquefaction, i.e.,
incomplete starch hydrolysis. IPS results in actual production loss due to
fining out. IPS
also plugs or slows filtration system, and fouls the carbon columns used for
purification.
When IPS reaches sufficiently high levels, it may leak through the carbon
columns and
decrease production efficiency. Additionally, it may results in hazy final
product upon
storage, which is unacceptable for final product quality.
[0028] The term "recombinant" when used in reference to a cell, nucleic acid,
protein or
vector, indicates that the cell, nucleic acid, protein or vector, has been
modified by the
introduction of a heterologous nucleic acid or protein or the alteration of a
native nucleic
acid or protein, or that the cell is derived from a cell so modified. Thus,
for example,
recombinant cells express genes that are not found within the native (non-
recombinant)
form of the cell, or express native genes that are otherwise abnormally
expressed, under
expressed or not expressed at all.
[0029] The terms "protein.' and "polypeptide" are used interchangeably herein.
[0030] The conventional one-letter or three-letter code for amino acid
residues is used herein.
[0031] A "signal sequence" means a sequence of amino acids bound to the N-
terminal
portion of a protein, which facilitates the secretion of the mature form of
the protein
outside the cell. The definition of a signal sequence is a functional one. The
mature form
of the extracellular protein lacks the signal sequence that is cleaved off
during the
secretion process.
9
CA 02771071 2012-02-06
WO 2011/017093
PCT/US2010/043369
[0032] A "gene" refers to a DNA segment that is involved in producing a
polypeptide and
includes regions preceding and following the coding regions as well as
intervening
sequences (introns) between individual coding segments (exons).
[0033] The term "nucleic acid" encompasses DNA, RNA, single stranded or double
stranded
and chemical modifications thereof. The terms "nucleic acid" and
"polynucleotide" may
be used interchangeably herein.
[0034] A "vector" refers to a polynucleotide sequence designed to introduce
nucleic acids
into one or more cell types, wherein the elements of the vector are operably
linked.
Vectors include cloning vectors, expression vectors, shuttle vectors,
plasmids, phage
particles, cassettes and the like.
[0035] An "expression vector" as used herein means a DNA construct comprising
a DNA
sequence that is operably linked to a suitable control sequence capable of
effecting
expression of the DNA in a suitable host. Such control sequences may include a
promoter to effect transcription, an optional operator sequence to control
transcription, a
sequence encoding suitable ribosome binding sites on the mRNA, enhancers and
sequences that control termination of transcription and translation.
[0036] A "promoter" is a regulatory sequence that is involved in binding RNA
polymerase to
initiate transcription of a gene. The promoter may be an inducible promoter or
a
constitutive promoter.
[0037] "Under transcriptional control" is a term well understood in the art
that indicates that
transcription of a polynucleotide sequence, usually a DNA sequence, depends on
its being
operably linked to an element that contributes to the initiation of, or
promotes
transcription.
[0038] "Under translational control" is a term well understood in the art that
indicates a
regulatory process that occurs after mRNA has been formed.
[0039] As used herein, when describing proteins and genes that encode them,
the term for the
gene is italicized, (e.g., the gene that encodes amyL (B. licheniformis AA)
may be
denoted as amyL). The term for the protein is generally not italicized and the
first letter is
CA 02771071 2012-02-06
WO 2011/017093
PCT/US2010/043369
generally capitalized (e.g., the protein encoded by the atnyL gene may be
denoted as
AmyL or amyL).
[0040] The term "derived" encompasses the terms "originated from," "obtained"
or
"obtainable from." and "isolated from."
[0041] The term "operably linked" refers to juxtaposition wherein the elements
are in an
arrangement allowing them to be functionally related. For example, a promoter
is
operably linked to a coding sequence if it controls the transcription of the
sequence.
[0042] The term "selective marker" refers to a gene capable of expression in a
host that
allows for ease of selection of those hosts containing an introduced nucleic
acid or vector.
Examples of selectable markers include but are not limited to antimicrobials
(e.g.,
hygromycin, bleomycin, or chloramphenicol) and/or genes that confer a
metabolic
advantage, such as a nutritional advantage on the host cell.
[0043] A polynucleotide or a polypeptide having a certain percent (e.g., about
80%, about
85%, about 90%, about 95%, or about 99%) of sequence identity with another
sequence
means that, when aligned, that percentage of bases or amino acid residues are
the same in
comparing the two sequences. This alignment and the percent homology or
identity can
be determined using any suitable software program known in the art, for
example those
described in CURRENT PROTOCOLS IN MOLECULAR BIOLOGY, Ausubel et al., eds.,
1987,
Supplement 30, section 7.7.18. Representative programs include the Vector NTI
AdvanceTM 9.0 (Invitrogen Corp. Carlsbad, CA), GCG Pileup, FASTA (Pearson et
al.
(1988) Proc. Nat'l Acad. Sci. USA 85:2444-2448), and BLAST (BLAST Manual,
Altschul et al., Nat'l Cent. Biotechnol. Inf., Nat'l Lib. Med. (NCIB NLM NIH),
Bethesda,
Md., and Altschul et al., (1997) Nucleic Acids Res. 25:3389-3402) programs.
Another
typical alignment program is ALIGN Plus (Scientific and Educational Software,
PA),
generally using default parameters. Another sequence software program that
finds use is
the TFASTA Data Searching Program available in the Sequence Software Package
Version 6.0 (Genetics Computer Group, University of Wisconsin, Madison, WI).
[0044] The term "parent" or "parent sequence" refers to a sequence that is
native or naturally
occurring in a host cell. Parent sequences include, but are not limited to,
the sequences of
11
CA 2771071 2017-03-02
WO 2011/017093
PCT/US2010/043369
Bacillus licheniformis alpha-amylase LAT (SEQ ID NO: 4).
[0045] "Variants" may have at least about 45%, at least about 50%, at least
about 55%, at
least about 60%, at least about 65%, at least about 70%, at least about 75%,
at least about
80%, at least about 85%, at least about 88%, at least about 90%, at least
about 91%, at
least about 92%, at least about 93%, at least about 94%, at least about 95%,
at least about
96%, at least about 97%, at least about 98%, at least about 99%, or at least
about 99.5%
sequence identity to a polypeptide sequence when optimally aligned for
comparison.
[0046] The term "property" or grammatical equivalents thereof in the context
of a
polypeptide, as used herein, refers to any characteristic or attribute of a
polypeptide that
can be selected or detected. These properties include, but are not limited to
oxidative
stability, substrate specificity, catalytic activity, thermal stability, pH
activity profile,
resistance to proteolytic degradation, Km, kcAr, kcAr/Km ratio, protein
folding, ability to
bind a substrate and ability to he secreted.
[0047] "Thermostable" or "thermostability" means the enzyme retains active
after exposure
to elevated temperatures. The therniostability of an alpha-amylase is
evaluated by its
half-life (t1/2), where half of the enzyme activity is lost at a given
temperature. The half-
life is measured by determining the specific alpha-amylase activity of the
enzyme
remaining over time at a given temperature, particularly at a temperature used
for a
specific application, e.g., liquefaction.
[0048] "Host strain" or "host cell" means a suitable host for an expression
vector or a DNA
construct comprising a polynucleotide encoding a variant alpha-amylase enzyme
according to the present disclosure. Specifically, host strains are typically
bacterial cells.
In a typical embodiment, "host cell" means both the cells and protoplasts
created from the
cells of a microbial strain and particularly a Bacillus sp.
[0049] The term "culturing" refers to growing a population of microbial cells
under suitable
conditions in a liquid or solid medium. In one embodiment, culturing refers to
fermentative bioconversion of a starch substrate containing granular starch to
an end
product (typically in a vessel or reactor), Fermentation is the enzymatic and
anaerobic
12
CA 02771071 2012-02-06
WO 2011/017093
PCT/US2010/043369
breakdown of organic substances by microorganisms to produce simpler organic
compounds. While fermentation occurs under anaerobic conditions it is not
intended that
the term be solely limited to strict anaerobic conditions, as fermentation
also occurs in the
presence of oxygen.
[0050] The term "enzymatic conversion" in general refers to the modification
of a substrate
by enzyme action. The term as used herein also refers to the modification of a
starch
substrate by the action of an enzyme.
[0051] As used herein, "Baume degrees" refer to the specific gravity of a
liquid. At 20 C,
the relationship between specific gravity (s.g.) and Baume degrees is:
= for liquids heavier than water: s.g. = 145 + (145 ¨Baume degrees); and
= for liquids lighter than water: s.g. = 140 + (Baume degrees + 130).
[0052] For starch suspensions, e.g., slurries and starch hydrolysates, the
Baume-dry
substance relationship is disclosed in Cleland J. et al., "Baume-Dry Substance
Tables for
Starch Suspensions," Ind. Eng. Chem. anal. Ed., 15: 334-36 (1943). See also,
"Critical
Data Tables," Corn Refiners Association, Inc. (1991). Baume degrees are useful
in the
corn wet milling industry for both process control and commercial sale of
hydrolysis
products.
[0053] As used herein, "saccharification" refers to enzymatic conversion of
starch to glucose.
[0054] "Gelatinization" means solubilization of a starch molecule by cooking
to form a
viscous suspension.
[0055] "Liquefaction" refers to the stage in starch conversion in which
gelatinized starch is
hydrolyzed to give low molecular weight soluble dextrins.
[0056] The term "degree of polymerization (DP)" refers to the number (n) of
anhydroglucopyranose units in a given saccharide. Examples of DPI are the
monosaccharides, such as glucose and fructose. Examples of DP2 are the
disaccharides,
such as maltose and sucrose. A DP>3 denotes polymers with a degree of
polymerization
of greater than 3.
13
CA 02771071 2012-02-06
WO 2011/017093
PCT/US2010/043369
[0057] The term "Dextrose Equivalent" (DE) value refers to the degree of
hydrolysis of
starch. It reflects the percentage of the total solids that have been
converted to reducing
sugars. A higher DE value underlies that more sugars and less dextrins are
present.
Along various stages of starch processing, glucose syrups having an above 55
DE value
are termed high conversion; between 35-55, regular conversion; below 20, the
products of
hydrolysis are maltins or maltodextrins.
[0058] The terms "end product- or "desired end product- refer to any carbon-
source derived
molecule product that is enzymatically converted from the starch substrate.
[0059] As used herein the term "dry solids content (ds)" refers to the total
solids of a slurry in
% on a dry weight basis.
[0060] The term "slurry" refers to an aqueous mixture containing insoluble
solids.
[0061] The term "residual starch" refers to the remaining starch (soluble or
insoluble) left in
a composition after fermentation of a starch-containing substrate.
[0062] As used herein, "a recycling step" refers to the recycling of mash
components, which
may include residual starch, enzymes and/or microorganisms to ferment
substrates
comprising starch.
[0063] The term "mash" refers to a mixture of a fermentable carbon source
(carbohydrate) in
water used to produce a fermented product, such as an alcohol. In some
embodiments,
the term "beer" and "mash" are used interchangeability.
[0064] The term "stillage" means a mixture of non-fermented solids and water,
which is the
residue after removal of alcohol from a fermented mash.
[0065] The terms "distillers dried grain (DDG)" and "distillers dried grain
with solubles
(DDGS)" refer to a useful by-product of grain fermentation.
[0066] As used herein, "ethanologenic microorganism" refers to a microorganism
with the
ability to convert a sugar or oligosaccharide to ethanol. The ethanologenic
microorganisms are ethanologenic by virtue of their ability to express one or
more
enzymes that individually or together convert sugar to ethanol.
14
CA 02771071 2012-02-06
WO 2011/017093
PCT/US2010/043369
[0067] As used herein, "ethanol producer" or "ethanol producing microorganism"
refers to
any organism or cell that is capable of producing ethanol from a hexose or
pentose.
Generally, ethanol-producing cells contain an alcohol dehydrogenase and a
pyruvate
decarboxylase. Examples of ethanol producing microorganisms include fungal
microorganisms such as yeast. The typical yeast used in ethanol production
includes
strains of Saccharomyces, e.g., S. cerevisiae.
[0068] The term "heterologous" with reference to a polynucleotide or protein
refers to a
polynucleotide or protein that does not naturally occur in a host cell. In
some
embodiments, the protein is a commercially important industrial protein. It is
intended
that the term encompass proteins that are encoded by naturally occurring
genes, mutated
genes, and/or synthetic genes.
[0069] The term "endogenous" with reference to a polynucleotide or protein
refers to a
polynucleotide or protein that occurs naturally in the host cell.
[0070] The terms "recovered," "isolated," and "separated" as used herein refer
to a
compound, protein, cell, nucleic acid or amino acid that is removed from at
least one
component with which it is naturally associated.
[0071] As used herein, "transformed,- "stably transformed" and "transgenic-
used in
reference to a cell means the cell has a non-native (e.g., heterologous)
nucleic acid
sequence integrated into its genome or as an episomal plasmid that is
maintained through
multiple generations.
[0072] As used herein, "expression" refers to the process by which a
polypeptide is produced
based on the nucleic acid sequence of a gene. The process includes both
transcription and
translation.
[0073] The term "introduced" in the context of inserting a nucleic acid
sequence into a cell,
means "transfection," or "transformation" or "transduction" and includes
reference to the
incorporation of a nucleic acid sequence into a cukaryotic or prokaryotic cell
wherein the
nucleic acid sequence may be incorporated into the genome of the cell (e.g.,
chromosome,
CA 02771071 2012-02-06
WO 2011/017093
PCT/US2010/043369
plasmid, plastid, or mitochondrial DNA), converted into an autonomous
replicon, or
transiently expressed (e.g., transfected mRNA).
[0074] As used herein, "specific activity" means an enzyme unit defined as the
number of
moles of substrate converted to product by an enzyme preparation per unit time
under
specific conditions. Specific activity is expressed as units (U)/mg of
protein.
[0075] The term "yield- refers to the amount of end products or desired end
products
produced using the methods of the present disclosure. In some embodiments, the
yield is
greater than that produced using methods known in the art. In some
embodiments, the
term refers to the volume of the end product and in other embodiment, the term
refers to
the concentration of the end product.
[0076] As used herein, "contacting" or "admixing" refers to the placing of the
respective
enzyme(s) in sufficiently close proximity to the respective substrate to
enable the
enzyme(s) to convert the substrate to the end product. Those skilled in the
art will
recognize that mixing solutions of the enzyme with the respective substrates
can effect
contacting or admixing.
[0077] "ATCC" refers to American Type Culture Collection located at Manassas,
Va. 20108
(ATCC).
[0078] "NRRL" refers to the Agricultural Research Service Culture Collection,
National
Center for Agricultural Utilization Research (and previously known as USDA
Northern
Regional Research Laboratory), Peoria, Ill.
[0079] "A," "an." and "the" include plural references unless the context
clearly dictates
otherwise.
[0080] As used herein, "comprising" and its cognates are used in their
inclusive sense; that is,
equivalent to the term "including" and its corresponding cognates.
1.2. Abbreviations
[0081] The following abbreviations apply unless indicated otherwise:
16
CA 02771071 2012-02-06
WO 2011/017093
PCT/US2010/043369
AA alpha-amylase
AAU alpha-amylase unit
AOS a-olefinsulfonate
AS alcohol sulfate
BAA bacterial alpha-amylase
cDNA complementary DNA
CMC carboxymethylcellulose
DDG distillers dried grains
DDGS distillers dried grain with solubles
DE Dextrose Equivalent
DNA deoxyribonucleic acid
DNS 3,5-dinitrosalicylic acid
DP3 degree of polymerization with three subunits
DPn degree of polymerization with n subunits
DS, ds dry solid
DSC differential scanning calorimetry
DTMPA diethyltriaminepentaacetic acid
EC enzyme commission for enzyme classification
EDTA ethylcnediaminetetraacetic acid
EDTMPA ethylenediaminetetramethylene phosphonic acid
EO ethylene oxide
FRED SPEZYMEC) FRED (SEQ ID NO: 6) (Danisco US Inc.,
Genencor Division)
F&HC fabric and household care
g gram
gal gallon
GAT J glucoamylase activity unit
HFCS high fructose corn syrup
HFSS high fructose starch based syrup
IPS iodine-positive saccharide (starch-positive saccharide)
IPTG isopropyl I3-D-thiogalactoside
LAS linear alkylbenczenesulfonate
17
CA 02771071 2012-02-06
WO 2011/017093
PCT/US2010/043369
LAT Bacillus lichenifortnis alpha-amylase (SEQ ID NO: 4)
LU Liquefon units
MES 2-(N-morpholino)ethanesulfonic acid
MW molecular weight
MWI J modified Wohlgemuth units
nm nanometer
NOBS nonanoyloxybenzenesulfonate
NTA nitrilotriacetic acid
PCR polymerase chain reaction
PEG polyethyleneglycol
pI isoelectric point
PNP-G7 p-nitrophenyl maltoheptoside
ppm parts per million
PVA poly(vinyl alcohol)
PVP poly(vinylpyrrolidone)
RAU Reference Amylase Units
RMS root mean square
RNA ribonucleic acid
rpm revolutions per minute
SAS secondary alkane sulfonates
s.g. specific gravity
lx SSC 0.15 M NaCl, 0.015 M sodium citrate, pH 7.0
SSF simultaneous saccharification and fermentation
TAED tetraacetylethylenediamine
TNBS trinitrobenzenesulfonic acid
w/v weight/volume
w/w weight/weight
wt wild-type
microliter
18
CA 02771071 2012-02-06
WO 2011/017093
PCT/US2010/043369
2. Starch Processing
2.1. Starch Substrates and Raw Materials
[0082] Those of skill in the art are well aware of available methods that may
be used to
prepare starch substrates for use in the processes disclosed herein. For
example, a useful
starch substrate may be obtained from tubers, roots, stems, legumes, cereals
or whole
grain. More specifically, the granular starch comes from plants that produce
high
amounts of starch. For example, granular starch may be obtained from corn,
cobs, wheat,
barley, rye, milo, sago, cassava, tapioca, sorghum, rice, peas, bean, banana,
or potatoes.
Corn contains about 60-68% starch; barley contains about 55-65% starch; millet
contains
about 75-80% starch; wheat contains about 60-65% starch; and polished rice
contains
about 70-72% starch. Specifically contemplated starch substrates are
cornstarch, wheat
starch, and barley starch. The starch from a grain may be ground or whole and
includes
corn solids, such as kernels, bran and/or cobs. The starch may be highly
refined raw
starch or feedstock from starch refinery processes. Various starches also are
commercially available. For example, cornstarch is available from Cerestar,
Sigma, and
Katayama Chemical Industry Co. (Japan); wheat starch is available from Sigma;
sweet
potato starch is available from Wako Pure Chemical Industry Co. (Japan); and
potato
starch is available from Nakaari Chemical Pharmaceutical Co. (Japan).
2.2. Milling
.. [0083] The starch substrate can be a crude starch from milled whole grain,
which contains
non-starch fractions, e.g., germ residues and fibers. Milling may comprise
either wet
milling or dry milling. In wet milling, whole grain is soaked in water or
dilute acid to
separate the grain into its component parts, e.g., starch, protein, germ, oil,
kernel fibers.
Wet milling efficiently separates the germ and meal (i.e., starch granules and
protein) and
is especially suitable for production of syrups. In dry milling, whole kernels
are ground
into a fine powder and processed without fractionating the grain into its
component parts.
Dry milled grain thus will comprise significant amounts of non-starch
carbohydrate
compounds, in addition to starch. Most ethanol comes from dry milling.
Alternatively,
the starch to be processed may be a highly refined starch quality, for
example, at least
about 90%, at least about 95%, at least about 97%, or at least about 99.5%
pure.
2.3. Gelatinization and Liquefaction
19
CA 02771071 2012-02-06
WO 2011/017093
PCT/US2010/043369
[0084] As used herein, the term "liquefaction" or "liquefy" means a process by
which starch
is converted to less viscous and shorter chain dextrins. This process involves
gelatinization of starch simultaneously with or followed by the addition of
alpha-
amylases. Additional liquefaction-inducing enzymes, e.g., a phytase,
optionally may be
added.
[0085] In some embodiments, the starch substrate prepared as described above
is slurried
with water. The starch slurry may contain starch as a weight percent of dry
solids of
about 10-55%, about 20-45%, about 30-45%, about 30-40%, or about 30-35%. To
optimize alpha-amylase stability and activity, the pH of the slurry may be
adjusted to the
optimal pH for the alpha-amylases. Alpha-amylases remaining in the slurry
following
liquefaction may be deactivated by lowering pH in a subsequent reaction step
or by
removing calcium from the slurry.
[0086] The slurry of starch plus the alpha-amylases may be pumped continuously
through a
jet cooker, which is steam heated from about 85 C to up to about 105 C.
Gelatinization
occurs very rapidly under these conditions, and the enzymatic activity,
combined with the
significant shear forces, begins the hydrolysis of the starch substrate. The
residence time
in the jet cooker is very brief. The partly gelatinized starch may be passed
into a series of
holding tubes maintained at about 85-105 C and held for about 5 min. to
complete the
gelatinization process. These tanks may contain baffles to discourage back
mixing. As
used herein, the term "secondary liquefaction" refers the liquefaction step
subsequent to
primary liquefaction, when the slurry is allowed to cool to room temperature.
This
cooling step can be about 30 minutes to about 180 minutes, e.g., about 90
minutes to 120
minutes. Milled and liquefied grain is also known as mash.
2.4. Saccharification
[0087] Following liquefaction, the mash is further hydrolyzed through
saccharification to
produce high glucose syrup that can be readily used in the downstream
applications. The
pH of the liquefied starch is generally adjusted to pH 4.2 to pH 4.5 using
diluted sulfuric
acid, and the liquefied starched is then incubated at 60 C for 36 to 96 hours.
During
saccharification, the hydrolysis is generally accomplished enzymatically by
the presence
of saccharification enzymes, i.e., a blend of glucoamylase and pullulanase.
CA 02771071 2012-02-06
WO 2011/017093
PCT/US2010/043369
Representative blends of saccharification enzymes are OPTIMAX 4060 VIIP
(Danisco
US Inc., Genencor Division) and Dextrozyme DX (Novozymes A/S). Typically, an
alpha-glucosidase and/or an acid alpha-amylase may also be supplemented in
addition of
the saccharification enzyme blend.
[0088] A full saccharification step may typically range 24 to 96 hours. In
some embodiments
for ethanol production, the saccharification step and fermentation step are
combined and
the process is referred to as simultaneous saccharification and fermentation
(SSF) or
simultaneous saccharification, yeast propagation and fermentation. In some
embodiments, a pre-saccharification step of about 1-4 hours may be included
between the
liquefaction step and the following saccharification / fermentation step.
2.5. Sweetener Production
[0089] When the desired final product from starch processing is high fructose
starch-based
syrup (HFSS), e.g., high fructose corn syrup (HFCS), the dextrose syrup from
the
saccharification process may be converted into fructose. The conversion is
typically
catalyzed by a glucose isomerase, e.g., GENSWEET (Danisco US Inc., Genencor
Division) and Sweetzyme (Novozymes, A/S). In brief, after the
saccharification
process, the pH is increased to a value in the range of about 6-8, typically
about 7.5, and
the calcium is removed by ion exchange. The dextrose syrup is then converted
into high
fructose syrup using, e.g., a glucose isomerases immobilized on a solid
support, such as
GENSWEEED JUT-HF (Danisco US Inc., Genencor Division).
3. Alpha-Amylases
3.1. Structure and Function
[0090] Alpha-amylases constitute a group of enzymes present in microorganisms
and
tissues from animals and plants. They are capable of hydrolyzing alpha-1, 4-
glucosidic
bonds of glycogen, starch, related polysaccharides, and some oligosaccharides.
Although
all alpha-amylases possess the same catalytic function, their amino acid
sequences vary
greatly. The sequence identity between different amylases can be virtually non-
existent,
e.g., falling below 25%. Despite considerable amino acid sequence variation,
alpha-
amylases share a common overall topological scheme that has been identified
after the
21
CA 02771071 2012-02-06
WO 2011/017093
PCT/US2010/043369
three-dimensional structures of alpha-amylases from different species have
been
determined. The common three-dimensional structure reveals three domains: (1)
a "TIM"
barrel known as domain A, (2) a long loop region known as domain B that is
inserted
within domain A, and (3) a region close to the C-terminus known as domain C
that
contains a characteristic beta-structure with a Greek-key motif. See van der
Maarel et al.,
J. Biotechnol. 94: 137-55 (2002).
[0091] The TIM barrel of domain A consists of eight alpha-helices and eight
parallel beta-
strands, i.e., (13/a)8, that alternate along the peptide backbone. This
structure, named after
a conserved glycolytic enzyme triosephosphate isomerase, has been known to be
common
among conserved protein folds. Domain B is a loop region inserted between pA3
and an3
(the third 13-strand and a-helix in domain A). Both domain A and domain B are
directly
involved in the catalytic function of an alpha-amylase, because the three-
dimensional
structure indicates that domain A flanks the active site and domain overlays
the active site
from on side. Furthermore, domain A is considered the catalytic domain, as
amino acid
residues of the active site are located in loops that link beta-strands to the
adjacent alpha-
helices. Domain B is believed to determine the specificity of the enzyme by
affecting
substrate binding. MacGregor et al.. Biochitn. Biophys. Acta. 1546:1-20
(2001).
3.2. Fuelzyme -LF Alpha-Amylases
[0092] One of the component of the presently described enzyme blend is the
Fuelzyme -LF
alpha-amylase (SEQ ID NO: 2), or an alpha-amylase that has about 80%, about
85%,
about 90%, about 95%, about 98%, about 99%, or about 99.5% amino acid sequence
identity to the Fuelzyme -LF alpha-amylase.
[0093] Fuelzyme -LF alpha-amylase (SEQ ID NO: 2) is an engineered enzyme
resulted
from a three-parent DNA shuffling. See Richardson et al., J. Biol. Chetn. 277:
26501-
95 26507 (2002); U.S. Patent No.: 7,323,336. The DNA encoding the parent
enzymes was
collected from microorganisms inhabiting a deep-sea hydrothermal vent. The 16
S rRNA
analysis suggested that the microorganisms belong to or have a very close
relationship
with Therntococcus sp. Fuelzyme -LF alpha-amylase has been characterized for
(1) its
superior liquefaction and viscosity reduction capability, and (2) its broad
temperature and
pH operating ranges. See, Sheridan C., "It Came From Beneath The Sea," Nat.
CA 2771071 2017-03-02
WO 2011/017093
PCT/US2010/043369
Biotechnol,, 23: 1199-201 (2005). The DNA sequence for Fuelzyme0-LF alpha-
amylase
and its genetic manipulation have been disclosed in U.S. Patent Nos.:
7,202,057;
7,273,740; 7,323,336; and 7,407,677.
Similarly, the production and purification of Fuelzyme -LF alpha-amylase or
related
enzymes have been described in detail in the above issued U.S. patents.
[0094] However, FuelzymeC)-LF alpha-amylase is presently limited in the
production of
biofuels, e.g., ethanol production, because it results in ineffectual glucose
syrup.
Specifically, saccharification of starch liquefact resulted from Fuelzyme0-LF
alpha-
amylase yielded iodine-positive saccharide (IPS) or blue saccharide. See
Examples infra.
Such an observation indicates that the saccharified starch is not suitable for
sweetener
applications, e.g., production of high glucose or fructose syrup.
3.3. B. lichenifonnis Alpha-Amylase and Variants Thereof
[0095] Another component of the presently described enzyme blend may be a
Termamyl-like
alpha-amylase from B. licheniformis. In one aspect, the B. licheniforrnis
alpha-amylases
may be wild-type parent enzymes, e.g., the alpha-amylase having an amino acid
sequence
of SEQ ID NO: 4. In another aspect, the alpha-amylase may be a variant of the
parent
enzyme. The variant alpha-amylase may contain one or more modifications of the
amino
acid sequence of a wild-type b. licheniformis alpha-amylase. A wild-type B.
licheniformis alpha-amylase may be isolated from any naturally occurring
strain of B.
licheniformis. For the purpose of this disclosure, an amino acid substitution
may be
designated MIST, for instance, "MIST" means that a methionine (M) residue at
position
15 is replaced with a threonine (T) residue, where the amino acids are
designated by
single letter abbreviations commonly known in the art.
[0096] A particularly useful alpha-amylase from B. licheniformis is SPEZYME0
FRED
(SEQ ID NO: 6), commercially available from Danisco US Inc., Cienencor
Division. This
alpha-amylase may be referred to herein as "FRED" (SEQ ID NO: 6).
[0097] Protein engineering of a wild-type B. licheniformis alpha-amylase
generates variant
alpha-amylases that can have improved properties. In one aspect, one or more
amino acid
residues of the variant enzyme are modified randomly, and the effect of the
modifications
is determined by subsequent analysis of the performance characteristics of the
variant,
23
CA 02771071 2012-02-06
WO 2011/017093
PCT/US2010/043369
following host cell expression of the variant. In another aspect,
modifications to the
amino acid sequence of the variant are made systematically, using a "model"
alpha-
amylase having a structure very similar to the wild-type B. lichen4bnnis alpha-
amylase as
a guide, so that the effect of the modifications can be predicted.
[0098] If a model alpha-amylase is used to guide the design of amino acid
changes of the
variant alpha-amylase, it is not necessary to know precisely which residues of
the model
alpha-amylase contribute to the performance of the enzyme. Instead, one or
more amino
acids, even an entire set of amino acids, are modified in the variant alpha-
amylase to the
corresponding amino acid(s) of the model alpha-amylase. A "corresponding"
amino acid
in this case is not determined by a conventional alignment of the primary
amino acid
sequence, but by a three-dimensional structural alignment of the polypeptide
backbone of
the two enzymes. Amino acids to be modified in the variant thus can be chosen
as
charged residues on the enzyme surface, active site residues, or residues that
contribute to
particular secondary structural elements unique to the model enzyme, for
example. The
residues to be modified also can be selected on the basis that the
modification would not
disrupt conserved three-dimensional structures between the two enzymes,
particularly
conserved secondary structural elements, e.g., a-helices, 3-sheets, turns.
[0099] For example, it is known that changing the distribution of charged
amino acids on the
surface of an enzyme generally can alter its enzymatic properties. See, e.g.,
Russell et al.,
"Rational modification of enzyme catalysis by engineering surface charge,"
Nalure 328:
496-500 (1987). One or more residues on the surface of the B. licheniformis
alpha-
amylase likewise can be modified to alter the enzymatic properties of the
variant alpha-
amylase, where the choice of modifications can be guided by the distribution
of surface
charges on the model alpha-amylase. For this purpose, a "surface charge" is
contributed
by a charged side chain of an amino acid that is at least partially exposed to
solvent.
[00100] A residue of the variant alpha-amylase can be classified as belonging
to one of three
structural domains, herein called domains A, B and C. For the purpose of this
disclosure,
domain A extends from residues 2-105 and from residues 208-396; domain B
extends
from residues 106-207; and domain C extends from residue 397 to the C terminus
of the
protein. An amino acid also can be classified as an active site residue.
Active site
24
CA 2771071 2017-03-02
WO 2011/017093
PCT/US2010/043369
residues are located at least at positions 49, 52,163, 167, 170, 172, 187,
188, 190, 238,
262, 264, 293, 297, and 332-334. Residue "positions" are numbered as depicted
in the B.
licheniformis alpha-amylase sequence (SEQ ID NO: 4).
[0100] In the variant alpha-amylase, one or more amino acid can be modified to
the
corresponding amino acid in the model alpha-amylase. The modifications may be
clustered by domain, and/or they may be clustered by amino acids that are
charged and
present on the surface of the enzyme, Alternatively or in addition,
modifications may be
made to one or more active site residues. In this manner, it is possible to
make multiple
amino acid modifications, where the modifications have a predictable effect on
the
performance characteristics of the variant alpha-amylase. For example, the
variant may
have every surface charged residue in one or more domain changed to the
corresponding
residue of the model alpha-amylase. In another embodiment, the variant may
have
residues inserted or deleted, e.g., a loop may be inserted or deleted, such
that the
polypeptide backbone of the variant more closely resembles the structure of
the model
alpha-amylase. Accordingly, the variant may comprise 1, 2, 3, 4, 5, 10, 15,
20, 30, 40,50,
60 or 70 amino acid substitutions, deletions or insertions, or any integer
value in between,
provided the variant retains alpha-amylase activity. The surface charge of the
variant also
may be altered by any number. For example, the number of positively charged
amino acid
residues on the enzyme surface may be reduced by 1, 2, 3, 4, 5, 6, 7 or 8.
Such amino acid
substitutions are expected to change the isoelectric point (pI) of the
variant, among other
things. Other characteristics of the variant may differ from the wild-type
enzyme, as
described below.
[0101] In another aspect, the variant alpha-amylase may have about a 50%, 55%,
60%, 65%,
70%, 75%, 80%, 85%, 90%, 95%, or 99% sequence identity to a Termamyl-like
alpha-
amylase from B. licheniforrnis. In another aspect, the variant alpha-amylase
may have
about a 50%, 55%, 60%, 65%, 70%, 75%, 80%, 85%, 90%, 95%, or 99% sequence
identity to B. licheniformis alpha-amylase LAT (SEQ ID NO: 4). Contemplated
variants
are described in WO 95/35382, WO 96/23874, WO 97/41213, and WO 99/19467.
CA 2771071 2017-03-02
WO 2011/017093
PCT/US2010/043369
[0102] In yet another aspect, the blend may contain at least about 0.5, about
1.0, about 11,
about 1.2, about 1.3, about 1.4, about 1.5, about 1.6, about 1,7, about 1.8,
about 1.9, about
2.0, about 2.5, about 3.0, about 3.5, about 4.0, about 4.5, or about 5.0
Liquefon Units
(Ws) of the B. licheniformis alpha-amylase for every 5.0 Modified Wohlgemuth
Units
(MWUs) of the low pH, thennostable alpha-amylase.
[0103] In another aspect, the variant alpha-amylase may have about a 50%, 55%,
60%, 65%,
70%, 75%, 80%, 85%, 90%, 95%, or 99% sequence identity to a Terrnamyl-like
alpha-
amylase.
[0104] In some embodiments, a variant B. licheniforrnis alpha-amylase may
display one or
more altered properties compared to those of the parent enzyme, e.g., the
alpha-amylase
having the amino acid sequence of SEQ ID NO; 4. The altered properties may
advantageously enable the variant alpha-amylase to perform effectively in
liquefaction.
Similarly, the altered properties may result in improved performance of the
variant
compared to its parent. These properties may include substrate specificity,
substrate
binding, substrate cleavage pattern, thermal stability, pH/activity profile,
pH/stability
profile, stability towards oxidation, stability at lower levels of calcium ion
(Ca2+), and/or
specific activity. Representative alpha-amylase variants, which can be useful
in the
present disclosure, include, but are not limited to those described in US
2008/0220476,
published Sept. 11, 2008; US 2008/0160573, published July 3, 2008; US
2008/0153733,
published June 26, 2008; US 2008/0083406, published Apr. 10, 2008; U.S.S.N.
12/263,804, filed Nov. 3, 2008; and U.S.S.N. 12/263,886, filed Nov. 3, 2008.
[0105] Alpha-amylase activity may be determined according to the method
disclosed in U.S.
Patent No. 5,958,739, with minor modifications. In brief, the assay uses p-
nitrophenyl
maltoheptoside (PNP-07) as the substrate with the non-reducing terminal sugar
chemically
- blocked. PNP- 07 can be cleaved by an endo-amylase, for example alpha-
amylase.
Following the cleavage, an alpha-glucosidase and a glucoamylase digest the
substrate to
liberate free PNP molecules, which display a yellow color and can be measured
by visible
spectophometry at 410 nm. The rate of PNP release is proportional to alpha-
amylase
activity. The alpha-amylase activity of a sample is calculated against a
standard control.
26
CA 02771071 2012-02-06
WO 2011/017093
PCT/US2010/043369
[0106] Enzyme variants can be characterized by nucleic acid and polypeptide
sequences, by
their 3D structures as described above, and/or by their specific activity.
Additional
features of the alpha-amylase variant include substrate specificity, half-
life, stability at
lower levels of calcium ion (Ca2+), pH range, oxidation stability, and
thermostability. In
one aspect, the alpha-amylase variants may have higher specific activities,
which can be
assessed using standard assays known to the artisan skilled in this field. In
another aspect,
variants demonstrate other improved performance characteristics, such as
improved
stability at high temperatures (i.e., 70-120 C), and/or pH extremes (i.e.,
about pH 4.0 to
about 6.0 or about pH 8.0 to about 11.0), and/or calcium concentrations below
about 60
PPIn=
[0107] Altered substrate specificity may include altered substrate binding
and/or altered
substrate cleavage pattern. The altered substrate binding may refer to
increased or
decreased binding ability to a given substrate. Altered substrate cleavage
pattern may
refer to increased or decreased cleavage efficiency as compared to the parent
enzyme.
[0108] Altered Ca2+ stability means the stability of the enzyme under Ca2+
depletion has been
altered, i.e., increased or decreased. Mutations of importance include those
that alter Ca2+
stability and requirements, in particular those with decreased Ca2 dependence
on at high
pH, i.e., pH 8.0 to 10.5.
[0109] Altered pH profile means that the performance of the enzyme under
different pH
values has been altered. The altered pH profile may include altered pH
activity profile,
which refers to increased or decreased specific activity under a given range
of pH.
Additionally, altered pH profile may also include altered pH stability
profile, which refers
to increased or decreased stability under a given range of pH.
[0110] In a further aspect, important mutations exhibit altered specific
activity, especially at
temperatures from about 10 C to about 60 C, particularly about 20 C to about
50 C, and
more particularly about 30 C to about 40 C, for use in cleaning compositions.
[0111] Alpha-amylase variants also may have altered oxidation stability, in
particular higher
oxidation stability, in comparison to the parent alpha-amylase. For example,
increased
27
CA 02771071 2012-02-06
WO 2011/017093
PCT/US2010/043369
oxidation stability is advantageous in detergent compositions, and decreased
oxidation
stability may be advantageous in composition for starch liquefaction.
[0112] The variant alpha-amylase may be more thermostable than the wild-type
alpha-
amylase. Such alpha-amylase variants are advantageous for use in baking or
other
processes that require elevated temperatures. For example, a thermostable
alpha-amylase
variant can degrade starch at temperatures of about 55 C to about 80 C or
more. A
thermostable alpha-amylase variant may retain its activity after exposure to
temperatures
of up to about 95 C.
[0113] The alpha-amylase variant polypeptides described herein can also have
mutations that
extend half-life relative to the parent enzyme by at least about 10%, about
20%, about
30%, about 40%, about 50%, about 60%, about 70%, about 80%, about 90%, about
100%,
about 200% or more, particularly at elevated temperatures of at least about 55
C to about
95 C or more, particularly at about 80 C. In one embodiment, the alpha-amylase
variant
can be heated for about 1-10 minutes at about 80 C or higher.
.. [0114] The alpha-amylase variants may have exo-specificity, measured by exo-
specificity
indices described herein, for example. Alpha-amylase variants include those
having
higher or increased exo-specificity compared to the parent enzymes or
polypeptides from
which they were derived, typically when measured under identical conditions.
Thus, for
example, the alpha-amylase variant polypeptides may have an exo-specificity
index of
about 10%, about 20%, about 30%, about 40%, about 50%, about 60%, about 70%,
about
80%, about 90%, about 100%, about 150%, about 200%, about 500%, about 1000%,
about
5000%, about 10,000% or higher compared to their parent polypeptides.
[0115] In one aspect, the alpha-amylase variant polypeptide encoded by the
nucleic acid has
the same pH stability as the parental sequence. In another aspect, the variant
comprises a
mutation that confers a greater pH stability range or shifts the pH range to a
desired area
for the end commercial purpose of the enzyme. For example, in one embodiment,
the
variant can degrade starch at about pH 5.0 to about pH 10.5. The alpha-amylase
variant
polypeptide may have a longer half-life or higher activity (depending on the
assay)
compared to the parent polypeptide under identical conditions, or the alpha-
amylase
variant may have the same activity as the parent polypeptide. The alpha-
amylase variant
28
CA 02771071 2012-02-06
WO 2011/017093
PCT/US2010/043369
polypeptide also may have about 10%, 20%, 30%, 40%, 50%, 60%, 70%, 80%, 90%,
100%, 200% or longer half-life compared to their parent polypeptide under
identical pH
conditions. Alternatively, or in addition, the enzyme variant may have higher
specific
activity compared to the parent polypeptide under identical pH conditions.
[0116] In another aspect, a nucleic acid complementary to a nucleic acid
encoding any of the
alpha-amylase variants set forth herein is provided. Additionally, a nucleic
acid capable of
hybridizing to the complement is provided. In another embodiment, the sequence
for use
in the methods and compositions described here is a synthetic sequence. It
includes, but is
not limited to, sequences made with optimal codon usage for expression in host
organisms,
such as the methylotrophic yeasts Pichia and Hansenula.
4. Production and Purification of B. licheniformis Alpha-Amylases
[0117] A DNA sequence encoding the enzyme variant produced by methods
described
herein, or by any alternative methods known in the art, can be expressed, in
enzyme form,
using an expression vector which typically includes control sequences encoding
a suitable
promoter, operator, ribosome binding site, translation initiation signal, and,
typically, a
repressor gene or various activator genes.
4.1. Vectors
[0118] The recombinant expression vector carrying the DNA sequence encoding an
alpha-
amylase variant may be any vector that may conveniently be subjected to
recombinant
DNA procedures, and the choice of vector will often depend on the host cell
into which it
is to be introduced. Thus, the vector may be an autonomously replicating
vector, i.e., a
vector that exists as an extrachromosomal entity, the replication of which is
independent of
chromosomal replication, e.g., a plasmid, a bacteriophage or an
extrachromosomal
95 element, mini-chromosome or an artificial chromosome. Alternatively, the
vector may be
one which, when introduced into a host cell, is integrated into the host cell
genome and
replicated together with the chromosome(s) into which it has been integrated.
The
integrated gene may also be amplified to create multiple copies of the gene in
the
chromosome by use of an amplifiable construct driven by antibiotic selection
or other
29
CA 02771071 2012-02-06
WO 2011/017093
PCT/US2010/043369
selective pressure, such as an essential regulatory gene or by complementation
of an
essential metabolic pathway gene.
[0119] An expression vector typically includes the components of a cloning
vector, e.g., an
element that permits autonomous replication of the vector in the selected host
organism
and one or more phenotypically detectable markers for selection purposes. The
expression
vector normally comprises control nucleotide sequences encoding a promoter,
operator,
ribosome binding site, translation initiation signal and typically, a
repressor gene or one or
more activator genes. In one aspect, all the signal sequences used target the
material to the
cell culture media for easier enzyme collection and purification. The
procedures used to
ligate the DNA construct encoding an alpha-amylase variant, the promoter,
terminator and
other elements, respectively, and to insert them into suitable vectors
containing the
information necessary for replication, are well known to persons skilled in
the art (see e.g.,
Sambrook et al., MOLECULAR CLONING: A LABORATORY MANUAL, 2nd ed., Cold Spring
Harbor, 1989 and 3rd ed., 2001).
[0120] In the vector, the DNA sequence should be operably connected to a
suitable promoter
sequence. The promoter may be any DNA sequence that shows transcriptional
activity in
the host cell of choice and may be derived from genes encoding proteins either
homologous or heterologous to the host cell. Examples of suitable promoters
for directing
the transcription of the DNA sequence encoding an alpha-amylase variant,
especially in a
bacterial host, are the promoter of the lac operon of E. coli, the
Sireptornyces coelicolor
agarase gene dagA or celA promoters, the promoters of the Bacillus
lichenifonnis alpha-
amylase gene (amyL), the promoters of the Bacillus stearothermophilus
maltogenic
amylase gene (amyM), the promoters of the Bacillus amyloliquefaciens alpha-
amylase
(atnyQ), the promoters of the Bacillus subtilis xylA and xylB genes, etc. For
transcription
in a fungal host, examples of useful promoters are those derived from the gene
encoding
Aspergillus oryzae TAKA amylase, Rhizomucor tniehei aspartic proteinase,
Aspergillus
niger neutral alpha-amylase, A. niger acid stable alpha-amylase, A. niger
glucoamylase,
Rhizomucor miehei lipase, A. oryzae alkaline protease, A. oryzae triose
phosphate
isomerase, or A. iiiduLtis acetamidase. When the gene encoding the alpha-
amylase
variant polypeptide is expressed in a bacterial species such as E. coli, a
suitable promoter
can be selected, for example, from a bacteriophage promoter including a T7
promoter and
CA 02771071 2012-02-06
WO 2011/017093
PCT/US2010/043369
a phage lambda promoter. Examples of suitable promoters for the expression in
a yeast
species include but are not limited to the Gal 1 and Gal 10 promoters of
Saccharomyces
cerevisiae and the Pichia pastoris A0X1 or A0X2 promoters. For expression in
Trichoclerma reesei, the CBHII promoter also may be used.
[0121] The expression vector may also comprise a suitable transcription
terminator and, in
eukaryotes, polyadenylation sequences operably connected to the DNA sequence
encoding
the alpha-amylase variant. Termination and polyadenylation sequences may
suitably be
derived from the same sources as the promoter. The vector may further comprise
a DNA
sequence enabling the vector to replicate in the host cell in question.
Examples of such
sequences are the origins of replication of plasmids pUC19, pACYC177, pUB110,
pE194,
pAMB1, pICatH, and pIJ702.
[0122] The vector may also comprise a selectable marker, e.g., a gene the
product of which
complements a defect in the host cell, such as the dal genes from B. subtilis
or B.
licheniformis, or a gene which confers antibiotic resistance, e.g.,
ampicillin, kanamycin,
chloramphenicol or tetracyclin resistance. Furthermore, the vector may
comprise
Aspergillus selection markers such as aindS, argB, Man and xxsC, a marker
conferring
hygromycin resistance, or the selection may be accomplished by co-
transformation as
known in the art. See, e.g., WO 91/17243.
4.2. Variant Expression and Host Organisms
[0123] While intracellular expression or solid-state fermentation may be
advantageous in
some respects, e.g., when using certain bacteria or fungi as host cells, it is
generally
advantageous if the expression of the variant is extracellular and into the
culture medium.
In general, the Bacillus alpha-amylases mentioned herein comprise a signal
sequence that
permits secretion of the expressed protease into the culture medium. If
desirable, this
signal sequence may be replaced by a different signal sequence, which is
conveniently
accomplished by substitution of the DNA sequences encoding the respective
signal
sequence. The signal sequences are typically characterized as having three
domains, an N-
terminal domain, an H-domain, and a C-terminal domain and range from 18 to 35
residues
in length.
31
CA 02771071 2012-02-06
WO 2011/017093
PCT/US2010/043369
[0124] The mature protein can be in the form initially of a fusion protein to
a pre-protein
derived from another Bacillus sp. or from the same species as the parental
sequence. To
secrete proteins in B. licheniformis, the signal peptide of B. licheniformis
alpha-amylase is
frequently used; however, signal proteins from other Bacillus sp. alpha-
amylases can also
be substituted.
[0125] An isolated cell, comprising either a DNA construct or an expression
vector, is
advantageously used as a host cell in the recombinant production of an alpha-
amylase
variant. The cell may be transformed with the DNA construct encoding the
variant,
conveniently by integrating the DNA construct (in one or more copies) in the
host
chromosome. This integration is generally considered to be an advantage as the
DNA
sequence is more likely to be stably maintained in the cell. Integration of
the DNA
constructs into the host chromosome may be performed according to conventional
methods, e.g., by homologous or heterologous recombination. Alternatively, the
cell may
be transformed with an expression vector as described above in connection with
the
different types of host cells.
[0126] Examples of suitable bacterial host organisms are Gram positive
bacterial species
such as Bacillaceae, including B. subtilis, B. licheniformis, B. lentus, B.
brevis, B.
stearothermophilus, B. alkalophilus, B. amyloliquefaciens, B. coagulans, B.
lautus, B.
megaterium, and B. thuringiensis; Streptomyces sp., such as S. murinus; lactic
acid
bacterial species including Lactococcus sp., such as L. lactis; Lactobacillus
sp. including
L. reuteri; Leuconostoc sp.; Pediococcus sp.; and Streptococcus sp.
Alternatively, strains
of a Gram negative bacterial species belonging to Enterobacteriaceae,
including E. coli, or
to Pseudomonadaceae can be selected as the host organism.
[0127] A suitable yeast host organism can be selected from biotechnologically
relevant
yeasts species, such as, but not limited to, Pichia sp., Hansenula sp.,
Kluyveromyces sp.,
Yarrowinia sp., Saccharomyces sp., including S. cerevisiae, or a species
belonging to
Schizosaccharotnyces, such as S. pombe. A strain of the methylotrophic yeast
species
Pichia pasloris can be used as the host organism. Alternatively, the host
organism can be
a Hansenula species. Suitable host organisms among filamentous fungi include
species of
Aspergillus, e.g., A. niger, A. oryzae, A. tubigensis, A. awamori, or A.
nidulans.
CA 02771071 2012-02-06
WO 2011/017093
PCT/US2010/043369
Alternatively, a strain of Fusariutn sp., e.g., Fusarium oxysporum or
Rhizomucor sp., such
as R. miehei, can be used as the host organism. Other suitable yeasts include
Thermotnyces sp. and Mucor sp. Fungal cells may be transformed by a process
involving
protoplast formation and transformation of the protoplasts followed by
regeneration of the
cell wall in a manner known in the art. A suitable procedure for transforming
Aspergillus
host cells, for example, is described in European Patent No. 238023.
[0128] In a yet further aspect, a method of producing an alpha-amylase variant
is provided,
which method comprises cultivating a host cell as described above under
conditions
conducive to the production of the variant and recovering the variant from the
cells and/or
culture medium. The medium used to cultivate the cells may be any conventional
medium
suitable for growing the host cell in question and obtaining expression of the
alpha-
amylase variant. Suitable media and media components are available from
commercial
suppliers or may be prepared according to published recipes, e.g., as
described in
catalogues of the American Type Culture Collection (ATCC). Exemplary culture
media
include but are not limited to those for fed-batch fermentations performed in
for example a
three thousand liter (3,000 L) stirred tank fermentor, which was used in the
examples
provided infra. The media used would be that most suitable for the host cell
being
cultured, for example the media discussed below for culturing Bacillus
licheniformis. The
growth medium in that case can consist of corn steep solids and soy flour as
sources of
organic compounds, along with inorganic salts as a source of sodium,
potassium,
phosphate, magnesium and sulfate, as well as trace elements. Typically, a
carbohydrate
source such as glucose is also part of the initial medium. Once the culture
has established
itself and begins growing, the carbohydrate is metered into the tank to
maintain the culture
as is known in the art. Samples are removed from the fermentor at regular
intervals to
measure enzyme titer using, for example, a colorimetric assay method. The
fermentation
process is halted when the enzyme production rate stops increasing according
to the
measurements.
[0129] An alpha-amylase variant secreted from the host cells may conveniently
be recovered
from the culture medium by well-known procedures, including separating the
cells from
the medium by centrifugation or filtration, and precipitating proteinaceous
components of
the medium by means of a salt such as ammonium sulfate, followed by the use of
33
CA 02771071 2012-02-06
WO 2011/017093
PCT/US2010/043369
chromatographic procedures such as ion exchange chromatography, affinity
chromatography, or the like.
[0130] Host cells may be cultured under suitable conditions that allow
expression of the
alpha-amylase variant proteins. Expression of the proteins may be
constitutive, such that
they are continually produced, or inducible, requiring a stimulus to initiate
expression. In
the case of inducible expression, protein production can be initiated when
required by
addition of an inducer substance, e.g., dexamethasone, IPTG, or Sepharose, to
the culture
medium, for example. Polypeptides can also be produced recombinantly in an in
vitro cell-
free system, such as the TnTTm (Promega) rabbit reticulocyte system.
[0131] An alpha-amylase variant expressing host also can be cultured under
aerobic
conditions in the appropriate medium for the host. Shaking or a combination of
agitation
and aeration can be provided, with production occurring at the appropriate
temperature for
that host, e.g., from about 30 C to about 75 C, depending on the needs of the
host and
production of the desired alpha-amylase variant. Culturing can occur from
about 12 to
about 100 hours or greater (and any hour value there between) or more
particularly from
about 24 to about 72 hours. Typically, the culture broth is at a pH of about
5.5 to about
8.0, again depending on the culture conditions needed for the host cell
relative to
production of the alpha-amylase variant.
4.3. Purification of Alpha-Amylases
[0132] Fermentation, separation, and concentration techniques are known in the
art and
conventional methods can be used in order to prepare the concentrated alpha-
amylase
variant containing solution. After fermentation, a fermentation broth is
obtained, and the
microbial cells and various suspended solids, including residual raw
fermentation
materials, are removed by conventional separation techniques to obtain an
amylase
solution. Filtration, centrifugation, microfiltration, rotary vacuum drum
filtration,
followed by ultra-filtration, extraction or chromatography, or the like are
generally used.
[0133] It is desirable to concentrate the solution containing the alpha-
amylase to optimize
recovery, since the use of un-concentrated solutions requires increased
incubation time to
collect precipitates containing the purified alpha-amylase variant. The
solution is
concentrated using conventional techniques until the desired enzyme level is
obtained.
34
CA 02771071 2012-02-06
WO 2011/017093
PCT/US2010/043369
Concentration of the enzyme variant containing solution may be achieved by any
of the
techniques discussed above. In one embodiment, rotary vacuum evaporation
and/or
ultrafiltration is used. Alternatively, ultrafiltration can be used.
[0134] By "precipitation agent" for purposes of purification is meant a
compound effective to
precipitate the alpha-amylase variant from the concentrated enzyme variant
solution in
solid form, whatever its nature may be, i.e., crystalline, amorphous, or a
blend of both.
Precipitation can be performed using, for example, a metal halide
precipitation agent.
Metal halide precipitation agents include: alkali metal chlorides, alkali
metal bromides and
blends of two or more of these metal halides. The metal halide may be selected
from the
group consisting of sodium chloride, potassium chloride, sodium bromide,
potassium
bromide and blends of two or more of these metal halides. Suitable metal
halides include
sodium chloride and potassium chloride, particularly sodium chloride, which
can further
be used as a preservative.
[0135] The metal halide precipitation agent is used in an amount effective to
precipitate the
alpha-amylase variant. The selection of at least an effective amount and an
optimum
amount of metal halide effective to cause precipitation of the enzyme variant,
as well as
the conditions of the precipitation for maximum recovery including incubation
time, pH,
temperature and concentration of alpha-amylase variant, will be readily
apparent to one of
ordinary skill in the art after routine testing.
[0136] Generally, at least about 5% w/v (weight/volume) to about 25% w/v of
metal halide
is added to the concentrated enzyme variant solution, and usually at least
about 8% vv/v.
Generally, no more than about 25% w/v of metal halide is added to the
concentrated
enzyme variant solution and usually no more than about 20% w/v. The optimal
concentration of the metal halide precipitation agent will depend, among
others, on the
nature of the specific alpha-amylase variant and on its concentration in the
concentrated
alpha-amylase variant solution.
[0137] Another alternative to effect precipitation of the enzyme is to use of
organic
compounds, which can be added to the concentrated enzyme variant solution. The
organic
compound precipitating agent can include: 4-hydroxybenzoic acid, alkali metal
salts of 4-
hydroxybenzoic acid, alkyl esters of 4-hydroxybenzoic acid, and blends of two
or more of
CA 02771071 2012-02-06
WO 2011/017093
PCT/US2010/043369
these organic compounds. The addition of the organic compound precipitation
agents can
take place prior to, simultaneously with or subsequent to the addition of the
metal halide
precipitation agent, and the addition of both precipitation agents, organic
compound and
metal halide, may be carried out sequentially or simultaneously. For a further
description,
see e.g., I J.S. Patent No. 5,281.526 (Danisco IJS Inc., Genencor Division).
[0138] Generally, the organic compound precipitation agents are selected from
the group
consisting of alkali metal salts of 4-hydroxybenzoic acid, such as sodium or
potassium
salts, and linear or branched alkyl esters of 4-hydroxybenzoic acid, wherein
the alkyl
group contains from 1 to 12 carbon atoms, and blends of two or more of these
organic
compounds. The organic compound precipitations agents can be for example
linear or
branched alkyl esters of 4-hydroxybenzoic acid, wherein the alkyl group
contains from 1
to 10 carbon atoms, and blends of two or more of these organic compounds.
Suitable
organic compounds include linear alkyl esters of 4-hydroxybenzoic acid,
wherein the alkyl
group contains from 1 to 6 carbon atoms, and blends of two or more of these
organic
compounds. Methyl esters of 4-hydroxybenzoic acid, propyl ester of 4-
hydroxybenzoic
acid, butyl ester of 4-hydroxybenzoic acid, ethyl ester of 4-hydroxybenzoic
acid and
blends of two or more of these organic compounds can also be used. Additional
organic
compounds also include, but are not limited to, 4-hydroxybenzoic acid methyl
ester
(methyl PARABEN) and 4-hydroxybenzoic acid propyl ester (propyl PARABEN),
which
are also amylase preservative agents.
[0139] Addition of the organic compound precipitation agent provides the
advantage of high
flexibility of the precipitation conditions with respect to pH, temperature,
alpha-amylase
variant concentration, precipitation agent concentration, and time of
incubation.
[0140] The organic compound precipitation agent is used in an amount effective
to improve
precipitation of the enzyme variant by means of the metal halide precipitation
agent. The
selection of at least an effective amount and an optimum amount of organic
compound
precipitation agent, as well as the conditions of the precipitation for
maximum recovery
including incubation time, pH, temperature and concentration of enzyme
variant, will be
readily apparent to one of ordinary skill in the art, in light of the present
disclosure, after
routine testing.
36
CA 02771071 2012-02-06
WO 2011/017093
PCT/US2010/043369
[0141] Generally, at least about 0.01% w/v of organic compound precipitation
agent is added
to the concentrated enzyme variant solution and usually at least about 0.02%
w/v.
Generally, no more than about 0.3% w/v of organic compound precipitation agent
is added
to the concentrated enzyme variant solution and usually no more than about
0.2% w/v.
[0142] The concentrated enzyme variant solution, containing the metal halide
precipitation
agent and, in one aspect, the organic compound precipitation agent, is
adjusted to a pH that
necessarily will depend on the enzyme variant to be purified. Generally, the
pH is
adjusted to a level near the isoelectric point (pI) of the amylase. For
example, the pH can
be adjusted within a range of about 2.5 pH units below the pI to about 2.5 pH
units above
the pI. For purposes of illustration, when the alpha-amylase variant is
derived from B.
licheniformis, the concentrated enzyme variant solution is usually adjusted to
a pH of
between about 5.5 and 9.7 and particularly to a pH of between about 6.5 and
9Ø The pH
may be adjusted accordingly if the pI of the variant differs from the wild-
type pI.
[0143] The incubation time necessary to obtain a purified enzyme variant
precipitate depends
on the nature of the specific enzyme variant, the concentration of enzyme, and
the specific
precipitation agent(s) and its (their) concentration. Generally, the time
effective to
precipitate the enzyme variant is between about 1 to about 30 hours: usually
it does not
exceed about 25 hours. In the presence of the organic compound precipitation
agent, the
time of incubation can still be reduced to less than about 10 hours, and in
most cases even
about 6 hours.
[0144] Generally, the temperature during incubation is between about 4 C and
about 50 C
Usually, the method is carried out at a temperature between about 10 C and
about 45 C,
and particularly between about 20 C and about 40 C. The optimal temperature
for
inducing precipitation varies according to the solution conditions and the
enzyme variant
95 or precipitation agent(s) used.
[0145] The overall recovery of purified enzyme variant precipitate, and the
efficiency with
which the process is conducted, is improved by agitating the solution
comprising the
enzyme variant, the added metal halide and the added organic compound. The
agitation
step is done both during addition of the metal halide and the organic
compound, and
37
CA 02771071 2012-02-06
WO 2011/017093
PCT/US2010/043369
during the subsequent incubation period. Suitable agitation methods include
mechanical
stiffing or shaking, vigorous aeration, or any similar technique.
[0146] After the incubation period, the purified enzyme variant is then
separated from the
dissociated pigment and other impurities and collected by conventional
separation
techniques, such as filtration, centrifugation, microfiltration, rotary vacuum
filtration,
ultrafiltration, press filtration, cross membrane microfiltration, cross flow
membrane
microfiltration or the like. Cross membrane microfiltration can be one method
used.
Further purification of the purified enzyme variant precipitate can be
obtained by washing
the precipitate with water. For example, the purified enzyme variant
precipitate is washed
with water containing the metal halide precipitation agent, for example, with
water
containing the metal halide and the organic compound precipitation agents.
[0147] During the culturing, thermostable amylase extracellularly accumulates
in the culture
broth. For the isolation and purification of the desired alpha-amylase
variant, the culture
broth is centrifuged or filtered to eliminate cells, and the resulting cell-
free liquid is used
for the purification of the enzyme. In one embodiment, the cell-free broth is
subjected to
salting out using ammonium sulfate at about 70% saturation; the 70% saturation-
precipitation fraction is then dissolved in a buffer and applied to a column
such as a
Sephadex 6-100 column, and eluted to recover the enzyme variant active
fraction. For
further purification, a conventional procedure such as ion exchange
chromatography may
be used.
[0148] Purified enzyme variants are useful for all applications in which the
enzyme variants
are generally utilized. For example, they can be used in laundry detergents
and spot
removers, in the food industry, in starch processing and baking, and in
pharmaceutical
compositions as digestive aids. They can be made into a final product that is
either liquid
95 (solution, slurry) or solid (granular, powder).
[0149] Alternatively, the enzyme product can be recovered and a flocculating
agent is added
to the media in order to remove cells and cell debris by filtration or
centrifugation without
further purification of the enzyme.
38
CA 02771071 2012-02-06
WO 2011/017093
PCT/US2010/043369
5. Other Enzymes Used in Starch Processing
5.1. Glucoamylases
[0150] Another enzyme contemplated for use in the starch processing,
especially during
saccharification, is a glucoamylase (EC 3.2.1.3). Glucoamylases are commonly
derived
from a microorganism or a plant. For example, glucoamylases can be of fungal
or
bacterial origin.
[0151] Exemplary fungal glucoamylases are Aspergillus glucoamylases, in
particular A. niger
G1 or G2 glucoamylase (Boel et al., EMBO J. 3(5): 1097-1102 (1984)), or
variants
thereof, such as disclosed in WO 92/00381 and WO 00/04136; A. awamori
glucoamylase
(WO 84/02921); A. oryzae glucoamylase (Hata et al., Agric. Biol, Chem., 55(4):
941-949
(1991)), or variants or fragments thereof. Other contemplated Aspergillus
glucoamylase
variants include variants with enhanced thermal stability: G137A and G139A
(Chen et al.,
Prot. Eng. 9: 499-505 (1996)); D257E and D293E/Q (Chen et al., Prot. Eng. 8:
575-582
(1995)); N182 (Chen et al., Biochem. J. 301: 275-281 (1994)); disulphide
bonds, A246C
(Fierobe et al., Biochemistry, 35: 8698-8704 (1996)); and introduction of Pro
residues in
positions A435 and S436 (Li et al., Protein Eng. 10: 1199-1204 (1997)).
[0152] Exemplary fungal glucoamylases may also include Trichoderma reesei
glucoamylase
and its homologs as disclosed in U.S. Patent No. 7,413,879 (Danisco US Inc.,
Genencor
Division). These glucoamylases include Trichoderma reesei glucoamylase (SEQ ID
NO:
4), Hypocrea ciirina var. americana glucoamylase (SEQ ID NO: 6), Hypocrea
viriosa
glucoamylase (SEQ ID NO: 8), Trichodenna sp. glucoamylase (SEQ ID NO: 10),
Hypocrea gelatinosa glucoamylase (SEQ ID NO: 12), Hypocrea orientalis
glucoamylase
(SEQ ID NO: 14), Trichoderma konilangbra glucoamylase (SEQ ID NO: 16),
Trichoderma sp. glucoamylase (SEQ ID NO: 29), Trichoderrna harziarturn
glucoamylase
(SEQ ID NO: 31), Trichodenna longibrachiatutn glucoamylase (SEQ ID NO: 33),
Trichodenna asperellum glucoamylase (SEQ ID NO: 35), and Trichodenna
strictipilis
glucoamylase (SEQ ID NO: 37).
[0153] Other contemplated glucoamylases include Talaromyces glucoamylases, in
particular
derived from T emersonii (WO 99/28448), 7'. leycettanus (U.S. Patent No. RE
32,153),
duponti, or T. thermophilus (U.S. Patent No. 4,587,215). Contemplated
bacterial
39
CA 2771071 2017-03-02
WO 2011/017093 PCT/US2010/043369
glucoamylases include glucoamylases from the genus Clostridium, in particular
C.
thernioamylolyticum (EP 135138) and C. thermohydrosullitricum (WO 86/01831).
[0154] Suitable glucoamylases include the glucoamylases derived from
Aspergillus oryzae,
such as a glucoamylase having about 50%, about 55%, about 60%, about 65%,
about 70%,
about 75%, about 80%, about 85%, or even about 90% identity to the amino acid
sequence
shown in SEQ ID NO: 2 in WO 00/04136. Suitable glucoamylases may also include
the
glucoamylases derived from Trichoderma reesei, such as a glucoamylase having
about
50%, about 55%, about 60%, about 65%, about 70%, about 75%, about 80%, about
85%,
or even about 90% identity to the amino acid sequence shown in SEQ ID NO: 1 or
3 in
.. WO 08/045489 (Danisco US Inc., Genencor Division). Trichoderrna reesei
glucoamylase
variants with altered properties, such as those disclosed in WO 08/045489 and
U.S.S.N.
12/292,563, filed Nov. 20, 2008 (Danisco US Inc., Genencor Division), may be
particularly useful.
[0155] Also suitable are commercial glucoamylases, such as Spirizyme Fuel,
Spirizyme
Plus, and Spirizyme Ultra (Novozymes A/S, Denmark), G-ZYME 480, G-ZYME
480 Ethanol, GC 147, DISTILLASE , and FERMENZYMEO (Danisco US Inc.,
Genencor Division). Glucoamylases may be added in an amount of 0.02-2.0 AGU/g
ds or
0.1-1.0 AGU/g ds, e.g., 0.2 AGU/g ds.
5.2. Pullulanase
[0156] Pullulanases (E.C. 3.2.1.41) are debranching enzymes characterized by
their ability to
hydrolyze the oi-1, 6-glyeosidic bonds in, for example, amylopectm and
puttulan.
Pullulanases have been found useful in various industrial applications,
particularly in the
food and beverage industries. Pullulanases are starch debranching enzymes and
are
effective in the debranching of starch hydrolysates (useful in conditioning
dough), the
debranching of beta-limit dextrans (useful in the brewing of beer and ales),
and in the
production of sugar syrups from starch-containing materials, such as corn,
potato, wheat,
manioc, and rice.
[0157] Pullulanase activity may be measured with the reducing sugars method as
described in
U.S. Patent No, 5,736,375. See also, Nelson
, CA 2771071 2017-03-02
WO 2011/017093
PCT/US2010/043369
N., "A Photometric Adaptation of the Somogyi Method for the Determination of
Glucose," J. Biol. Chem. 153: 375-80 (1944); Somogyi M., "A New Reagent for
the
Determination of Sugars," J. Biol. Chem, 160: 61-68 (1945).
[0158] Representative pullulanases include those from the genus Bacillus,
particularly the
pullulanase from Bacillus amyloderamificans as disclosed in US, Patent No.
4,560,651,
the pullulanase disclosed as SEQ ID NO: 2 in WO 01/051620, the pullulanase
from
Bacillus derainificans disclosed as SEQ ID NO: 4 in WO 01/051620, and the
pullulanase
from Bacillus acidopullulyticus disclosed as SEQ Ill NO: 6 in WO 01/051620.
See also, Kelly et al., "Molecular Genetic
analysis of the Pullulanase B Gene of Bacillus acidopullulyticus," FEMS
Microbiol. Lett.
115: 97-106 (1994).
[0159] Additionally, the pullulanase may be a variant of a naturally occurring
pullulanase.
The production of Bacillus deramificans pullulanase has been described in U.S.
Patent
Nos. 5,736,375 and 7,399,623.
.. [0160] Suitable commercially available pullulanases include PROMOZYME D,
PROMOZYMETM D2 (Novozymes A/S), OPTIMAX L-300 (Danisco US Inc., Genencor
Division), KLEISTASE PL45 and KLEISTASE PLF (Amano Enzyme Inc., Japan).
5.3. Glucose Isomerases
[0161] Commercial glucose isomerase is actually a xylose isomerase (D-xylose
ketol
isomerase, EC 5.3.1.5), an intracellular enzyme that catalyzes the
isomerization of D-
xylose to D-xylulose. However, the practical significance of the enzyme stems
from the
fact that the xylose isomerase can use either D-xylose or D-glucose as
substrates. The
enzyme's commercial use is mainly for high fructose syrup production. See
Kaneko et al.,
Biosci. Biotechnol. Biochem. 64:940-947 (2000)), At present, the commercial
glucose
isomerases come mainly from Actinoplanes rnissouriensis, Bacillus coagulans,
or
Streptomyces species. Contemplated isomerases included the commercial products
SweetzymeC), IT (Novozymes A/S); GENSWEETC) IGI SA, GENSWEETO IGI HF,
GENSWEETC) IGI VHF, GENSWEETC) SW, and GENSWEET IGI MAX (Danisco
US Inc., Genencor Division).
41
CA 02771071 2012-02-06
WO 2011/017093
PCT/US2010/043369
5.4. Phytases
[0162] Phytases are useful for the present disclosure as they are capable of
hydrolyzing
phytic acid under the defined conditions of the incubation and liquefaction
steps. In some
embodiments, the phytase is capable of liberating at least one inorganic
phosphate from an
inositol hexaphosphate (phytic acid). Phytases can be grouped according to
their
preference for a specific position of the phosphate ester group on the phytate
molecule at
which hydrolysis is initiated (e.g., as 3-phytases (EC 3.1.3.8) or as 6-
phytases (EC
3.1.3.26)). A typical example of phytase is myo-inositol-hexakisphosphate-3-
phosphohydrolase.
[0163] Phytases can be obtained from microorganisms such as fungal and/or
bacterial
organisms. Some of these microorganisms include e.g. Aspergillus (e.g., A.
niger, A.
(erreus, A. ficurn and A. firmigatus), Myceliophthora (M. therrnophila),
Talaromyces (T.
thertnophilus) Trichodertna spp (T. reesei). and Thennontyces (WO 99/49740).
Phytases
are also available from Penicillium species, e.g., P. hordei (ATCC No. 22053),
P. piceum
(ATCC No. 10519), or P. brevi-compactum (ATCC No. 48944). See, e.g. ,U U.S.
Patent No.
6,475,762. In addition, phytases are available from Bacillus (e.g., B.
subtilis,
Pseuclomonas, Peniophora. E. coli, Citrobacter, Enterbacter, and Buttiauxella
(see
W02006/043178)).
[0164] Commercial phytases are available such as NATUPHOS (BASF), RONOZYME P
(Novozymes A/S), and FINASE (AB Enzymes). The method for determining microbial
phytase activity and the definition of a phytase unit has been published by
Engelen et al.,
J. of AOAC Int., 77: 760-764 (1994). The phytase may be a naturally occurring
phytase, a
variant, or a fragment thereof.
[0165] In one embodiment, the phytase is one derived from the bacterium
Buttiauxiella spp.
The Buttiauxiella spp. includes B. agrestis, B. brennerae, B. ferragutiase, B.
gaviniae, B.
izardii, B. noackiae, and B. warmboldiae. Strains of Buttiauxella species are
available
from DSMZ, the German National Resource Center for Biological Material
(Inhoffenstrabe 7B, 38124 Braunschweig, Germany). Buttiauxella sp. strain P1-
29
deposited under accession number NCIMB 41248 is an example of a particularly
useful
strain from which a phytase may be obtained and used according to the present
disclosure.
42
CA 02771071 2012-02-06
WO 2011/017093
PCT/US2010/043369
In some embodiments, the phytase is BP-wild-type, a variant thereof (such as
BP-11)
disclosed in WO 06/043178, or a variant as disclosed in US 2008/0220498,
published
Sept. 11, 2008. For example, a BP-wild-type and variants thereof are disclosed
in Table 1
of WO 06/043178, wherein the numbering is in reference to SEQ ID NO: 3 of the
published PCT application.
5.5. Beta-Amylase
[0166] Another aspect contemplates the additional use of a beta-amylase. Beta-
amylases (EC
3.2.1.2) are exo-acting maltogenic amylases, which catalyze the hydrolysis of
1, 4-a-
glucosidic linkages into amylose, amylopectin, and related glucose polymers,
thereby
releasing maltose. Beta-amylases have been isolated from various plants and
microorganisms (Fogarty et al., PROGRESS IN INDUSTRIAL MICROBIOLOGY, Vol. 15,
pp.
112-115, 1979). These beta-amylases are characterized by having optimum
temperatures
in the range from 40 C to 65 C, and optimum pII in the range from about 4.5 to
about 7Ø
Contemplated 13-amylases include, but are not limited to, beta-amylases from
barley
SPEZYME0 BBA 1500, SPEZYME DBA, OPTIMALTTm ME, OPTIMALTTm BBA
(Danisco US Inc, Genencor Division); and NovozymTM WBA (Novozymes A/S).
EXAMPLES
[0167] The following examples are not to be interpreted as limiting, but are
exemplary
means of using the methods disclosed.
Materials and Methods
Fuelzyme -LF
[0168] Commercial product of Fuelzyme -LF (lot # 90BA031A1M1 activity 134,603
MWU/g) was provided by Brian A. Steer, Ph.D., Fuelzyme0-LF Product Manager,
Verenium Corporation, 4955 Directors Place, San Diego, CA 92121, Tel: 858-526-
5264,
Fax: 858-526-5764.
SPEZYME@ FRED and OPTIMAX@ 4060 VHP
[0169] SPEZYMEO FRED and OPTIMAX0 4060 VHP were from Danisco US Inc.,
Genencor Division (lot # 1077061001; activity 17662 AAUs/g).
43
CA 02771071 2012-02-06
WO 2011/017093
PCT/US2010/043369
Bradford Assay for Protein Content Determination in 96-well Microtiter Plate
[0170] Protein concentration in sample supernatants was determined using the
Bradford
QuickStartTM Dye Reagent (Bio-Rad, California). Samples were obtained by
filtration of
broths from cultures grown in microtiter plates (MTPs). The cultures were
grown for 3
days at 37 C with shaking at 280 rpm and humidified aeration. A 101.11_,
sample of the
culture filtrate was combined with 200 tit Bradford QuickStartTm Dye Reagent
in a well
of a second MTP. After thorough mixing, the MTP's were incubated for at least
10
minutes at room temperature. Air bubbles were removed, and the OD (optical
density)
was measured at 595 mm To determine the protein concentration, the background
reading
(from uninoculated wells) was subtracted from the sample readings.
Sediment Test
[0171] All starches, especially grain-based, contain traces of components
other than
dextrose polymers such as fine fiber, proteins, fats, and ash that are
released during
hydrolysis. The starch cooking parameters and operating equipment such as the
steam jet
cooker has a bearing on the quantity of this material. Small amounts of starch-
lipid
complexes and under the right conditions, partially pasted and/or whole starch
granules
may pass through the liquefaction system. Due to incomplete hydrolysis in the
liquefaction system, the most reliable location to test for these components
is after
complete saccharification. A well run liquefaction system that is receiving
well-washed
starch from the milling division should test at <1.5 % sediment by this
method. There are
systems that consistently deliver <1%. Operating history has shown that
sediment levels
above 2.5 % will result in down stream filtration difficulties, and thus costs
for pre-coat
media and/or microfilters.
[0172] This method described herein may be used for all dextrose substrates
>90 %
dextrose. This may also be used for maltose liquors, and liquefied low DE
products. Due
to viscosity and buoyant force issues caused by final saccharified dry
substances >5 %,
liquors known to be greater than this should be diluted prior to testing.
[0173] Samples of saccharified syrup were held in a 60 C water bath for 10-30
minutes to
bring them to a constant temperature. The incubation, however, should not be
longer than
one hour. The DS value was adjusted to 35% 0.5% prior to testing as
necessary.
44
CA 02771071 2012-02-06
WO 2011/017093
PCT/US2010/043369
Samples were mixed on a magnetic stirrer, and transferred to a centrifuge tube
using a
syringe. Samples were centrifuged at 2,500 rpm (1,350 x g) for 10 minutes. The
sediment, if present, was visible at the bottom of the centrifuge tube.
Filtration Test
[0174] This test is based on the filtration rate through a controlled depth of
filter aid
(diatomaceous earth) under controlled temperature and vacuum. This test can
identify
differences in liquefaction enzymes and processes, following saccharification.
This test is
suitable for the simulation of industrial rotary vacuum pre-coat filtration
systems. It may
be used for determination and demonstration of various liquefaction and
saccharification
enzymes and processes. In addition, the filtrate provides clean material for
further
evaluation such as the determination of soluble starch with iodine reaction.
[0175] Column jackets were maintained at 60 C. Two filter paper discs were
inserted and
screwed in the fitting until snug against the 0-ring gasket. While a tared 250
ml vacuum
flask was in place, 100 ml of water was added to the column with the exit
plugged. The
vacuum pump was turned on until a steady vacuum of 23-24 inches was achieved.
The
tube exit was turned on, and a timer was started. The 100 ml takes about 1 min
10 seconds
to 1 min 30 seconds to filter through the system. If not, then check the
papers to make
sure they are tight. After the papers were pulled to dryness, the exit tube
was clamped.
The pump was left running with the clamp removed from the exit tube. The flask
was
replaced with a tared 250 ml filter flask. Approximately 2.0 grams of filter
aid was mixed
with 100 grams of test liquor in a 250 ml beaker. While the sample was
stirring on the
magnetic plate, a syringe was used to remove the sample with targeted
quantity. A top
loading balance may be used for this step. While keeping the particulates in
suspension,
the entire quantity was rapidly transferred to the column with the aid of a
funnel. The exit
tube clamp was turned on, and a timer was started. Collect until the liquor
reaches the top
of the filter bed and record the time. The quantity of filtrate across
multiple tests may be
used to judge operating differences in liquefaction or saccharification.
Alternatively, the
rate may be calculated in weight or volume per square meter of filter bed.
[0176] For example, 60 grams of filtrated was collected in 15 minutes. The
area of filter
bed surface is calculated as ar2, in this case 3.141593 x 0.75 x 0.75 = 1.767
cm2(the
CA 02771071 2012-02-06
WO 2011/017093
PCT/US2010/043369
column has an inner radius of 0.75 cm). In addition, the 60 grams of filtrate
was
equivalent to 52 ml of the sample, which has a 35% DS and a density of 1.151
g/mL. The
filtrate rate is thus 52 m1/1.767 cm2/15 min = 1.96 ml/cm2/min.
Iodine Test
[0177] For saccharification liquor test, 0.2 ml saccharification liquor was
diluted with 10
ml of DI water. The diluted saccharification liquor was boiled for 10 minutes
and then
cooled in an ice bath. 0.5 ml iodine solution (0.02 M) was added to the cooled
saccharification liquor sample.
[0178] For filtrate test, 0.5 ml filtrate, which was obtained as described in
Example 1.3.,
was diluted with 10 ml of DI water. The diluted filtrate was boiled for 10
minutes and
cooled in an ice bath. 0.5 ml iodine solution (0.02 M) was added to the cooled
filtrate
sample.
HPLC method to measure the composition of glucose syrup
[0179] The composition of saccharification products was measured by a HPLC
system
(Beckman System Gold 32 Karat Fullerton, CA). The system, maintained at 50 C,
was
equipped with a Rezex 8 u8% H Monosaccharides column and a refractive index
(RI)
detector (ERC-7515A, Anspec Company, Inc.). Diluted sulfuric acid (0.01 N) was
applied
as the mobile phase at a flow rate of 0.6 ml/min. 20 t1 of 4.0% solution of
the reaction
mixture was injected onto the column. Elution profiles were obtained over 45
minutes.
The distribution of saccharides and the amount of each saccharide were
determined from
previously run standards.
Example 1. Comparison of Fuelzyme@-LF and SPEZYME FRED.
[0180] A 38 % DS refined starch (Cargill, Minneapolis, MN) slurry containing
10 ppm Ca2+
and 100 ppm sulfur dioxide (SO2) was prepared in a metal bucket with overnight
stirring.
The pII of the slurry was adjusted to pII 4.5, 5.6, and 5.8 using sodium
carbonate solution
(20% w/v). The slurry Baume (degrees) was approximately 22.3. Three sets of
liquefactions were performed with Fuelzyme -LF at different enzyme dosages and
specified pHs, and one set was performed with SPEZYME FRED. The liquefaction
was
46
CA 02771071 2012-02-06
WO 2011/017093
PCT/US2010/043369
carried out as follows: (1) Fuelzyme -LF at 50 MWUs/g ds at pII 4.5, (2)
Fuelzyme -LF
at 50 MWUs/g ds at pH 5.6, (3) Fuelzyme -LF at 25 MWUs/g ds at pH 5.6, and (4)
SPEZYME FRED at 10 LUs/g ds at pH 5.8.
[0181] The slurry with the enzyme(s) added was sent through a pilot plant jet
cooker (Hydro-
thermal Corporation, Waukesha, WI) at 0.5 gpm with six-minute residence time
and
cooked at about 108-110 C for the primary cook. Secondary liquefaction was
performed
at 95 C for 120 minutes. 'the DE and refractive index (RI) were measured at
various time
points during the secondary liquefaction (Table 1A).
Table 1A. DE development for Fuelzyme -LF and SPEZYME FRED
Enzyme Treatment Time min. D.E.
30 7.38
Fuelzyme -LF at 50 MWUs/g ds at pH 4.5 60 10.21
66 11.72
30 3.66
Fuelzyme -LF at 25 MWUs/g ds at pH 5.6 60 5.74
90 7.34
132 8.79
30 7.74
60 10.48
Fuelzyme -LF at 50 MWUs/g ds at p115.6
90 12.47
120 13.88
30 4.59
60 7.29
SPEZYME FRED at 10 LUs/g ds pH 5.8
90 9.59
103 10.57
[0182] The data in Table 1A show that the DE development during the secondary
liquefaction. Liquefaction with Fuelzyme -LF with a dose of 50 MWUs/g ds at
both pH
4.5 and 5.6 was able to generate 10 DE in 60 mm. Whereas, Fuelzyme -LF with 25
MWUs/g ds was not able to generate 10 DE even at 132 mm. This result shows
that the
DE development rate in secondary liquefaction was almost doubled by doubling
the
47
CA 02771071 2012-02-06
WO 2011/017093
PCT/US2010/043369
Fuelzyme -LF dosage as Fuelzyme -LF achieved 10 DE in half the time with 50
MWUs
compared to 25 MWUs. The secondary liquefaction with SPEZYME FRED generated
10.57 DE in 103 mm, which is a standard DE development rate with SPEZYME FRED
under used conditions.
[0183] The pH of the liquefact was adjusted to pH 4.2 and the DS was adjusted
to 34% DS.
The saccharification enzyme blend OPTIMAXO 4060 VHP was added at 0.16 GAErs/g
ds.
The saccharification was carried out at 60 C for 48-64 hours. At various time
points,
samples were taken and the composition of the reaction products were
determined by the
HPLC method (Table 1B).
Table 1B. High glucose syrup composition using liquefied starch from different
liquefying enzyme combinations.
Liquefying Enzymes DPs 24 hr 48hr
DP1 94.06 95.74
Fuelzyme -LF at 50 MWUs/g ds
DP2 1.64 1.90
at pH 4.5
DP3 0.85 2.36
DP1 91.38 94.515
Fuelzyme -LF at 25 MWUs/g ds
DP2 2.482 2.518
at pH 5.6
DP3 3.939 1.98
DP1 92.74 94.95
Fuelzyme -LF at 50 MWUs/g ds DP2 232 2.92
at pH 5.6
DP3 4.94 2.14
DP1 90.82 95.35
SPEZYME FRED at 10 LUs/g ds
DP2 2.48 2.82
pH 5.8
DP3 3.61 1.11
[0184] After the saccharification, the glucose syrup was tested for (1) iodine
test (Materials
and Methods), (2) sediment test (Materials and Methods), and (3) filtration
test (Materials
and Methods). The values were compiled in Table 1C.
Table 1C. The blue saccharide, sediment, filtration, and glucose results for
the
saccharification liquor from Fuelzyme -LF and SPEZYME FRED liquefact.
48
CA 02771071 2012-02-06
WO 2011/017093
PCT/US2010/043369
Filter
Sediment Iodine
Enzyme pH W15
Color
min
Fuelzyme0-LF at 50 MWUs/g ds 4.5 5 17 Blue
Fuelzymeq1)-LF at 25 MWIJs/g ds 5.6 15 11.22 Blue
Fuelzyme -LF at 50 MWUs/g ds 5.6 3 (Firm) 33.5 Blue
SPEZYME0 FRED at 10 LUs/g ds 5.8 0.5 67 Yellow
[0185] Due to incomplete hydrolysis of starch in the liquefaction system, the
high glucose
level observed at the end of the saccharification does not necessarily
indicate that the
saccharified starch is suitable for sweetener application. One of the most
reliable methods
is the iodine-positive saccharide (IPS; or blue saccharide) measured by the
iodine test.
The saccharified starch was subject to iodine test for both the filtrate and
the sediments.
Iodine is able to bind any amylose that escapes hydrolysis during
liquefaction/saccharification and produce a blue color, which is teimed iodine-
positive
saccharide. IPS is highly undesirable in sweetener applications. Both the
sediment and
the filtrate of the saccharified starch were subject to iodine test.
[0186] Also, the sediment test was performed after the saccharification.
Incompletely
hydrolyzed starch may be complexed with lipid, protein, and/or fine fiber to
form
sediments in the glucose syrup. A high level of sediments is undesirable for
sweetener
applications, because the sediments may substantially reduce filtration rate
requiring
addition of high level of filter aid resulting in higher cost and disposal
problems. This will
also reduce the plant capacity. A well-run liquefaction system that is
receiving well-
washed starch from the milling division generally results in sediment less
than 1.5% v/v.
[0187] The high glucose syrup obtained using liquefact from Fuelzyme0-LF
exhibited an
iodine-positive saccharide (IPS). When stained with iodine, the sediment and
filtrate
turned blue/green color (FIG. 1) indicating that amylose (DP > 46-54) is still
present after
saccharification for liquefact obtained from Fuelzymeg-LF. The liquefact is
thus
unacceptable for sweetener applications. The high glucose syrup obtained using
liquefact
from Fuelzyme0-LF also exhibited high level of sediments. Both results are
undesirable
for the production of HFCS (high fructose corn syrup).
49
CA 02771071 2012-02-06
WO 2011/017093
PCT/US2010/043369
[0188] The sediment or filtrate obtained from high glucose syrup using SPEZYME
FRED liquefact did not exhibit blue color when stained with iodine and turned
yellow
(FIG. 1), and showed lower level (<1.5%) of sediments, which is ideal in the
production of
HFCS.
[0189] Moreover, another reliable method to evaluate a saccharified starch is
the filtration
test, which is similar to the sediment test. The filtration rate is inversely
affected by the
amount of sediments. The filtration test results are compatible with what was
observed in
sediment test. See Table 1C. The saccharified starch from the various Fuelzyme
-LF
liquefact exhibited a low filtration rate , ranging from 11 to 33.5 g/15 mm.
Whereas, for
the saccharified starch from the liquefact by SPEZYME FRED, the filtration
rate
improved to 67 g/15 min, which is twice the rates of the Fuelzyme -LF
liquefact.
[0190] To fully realize the potential of this low pII, thermostable enzyme in
sweetener
applications, a blend combining Fuelzyme -LF and a Bacillus licheniformis
alpha-
amylase was tested to overcome the blue saccharide or IPS problems associated
with
Fuelzyme -LF in sweetener production and is explained in following examples.
Example 2. Fuelzyme -LF and SPEZYME FRED blend in starch liquefaction
[0191] Aqueous slurry containing 38% DS refined starch (Cargill, Minneapolis,
NM), 10
ppm Ca2+, and 100 ppm sulfur dioxide (SO2) was prepared by stirring overnight.
The pH
of the slurry was adjusted using sodium carbonate solution (20% w/v). The
Baume
(degrees) of the slurry were approximately 22.3. Single set of liquefaction
was performed
using 25 MWUs/g ds Fuelzyme -LF supplemented with 5 LUs/g ds of SPEZYME
FRED at pH 5.6. The slurry with the enzyme(s) added was sent through the big
jet at 0.5
gpm with six-minute residence time and cooked at about 108-110 C for the
primary cook.
Secondary liquefaction was performed at 95 C for 120 minutes. The DE and
refractive
index (RI) were measured at various time points during the secondary
liquefaction. Table
2A reflects the DE values determined at various time of secondary liquefaction
for the two
sets of liquefaction. The results indicate that at pH 5.6, the Fuelzyme -LF /
SPEZYME
FRED 25/5 blend is able to achieve DE development that is acceptable for
starch
liquefaction in sweetener applications, i.e., a DE value of at least 10 in 90-
100 min. The
CA 02771071 2012-02-06
WO 2011/017093
PCT/US2010/043369
data presented herewith suggest that the DE development during liquefaction by
the
Fuelzyme -LF/ SPEZYME FRED, 25/5 blend at pH 5.6 is compatible with the
industrial standard.
Table 2A.DE development for Fuelzyme -LF/ SPEZYME FRED blend at pH 5.6 and
5.3
Enzyme Treatment Time min. D.E.
30 5.53
Fuelzyme -LF/ SPEZYME FRED 25/5 60 8.47
blend at pH 5.6 90 10.66
120 12.47
[0192] Next, the suitability of the resulting liquefact in sweetener
applications was tested in
the saccharification. The liquefact was adjusted to pH 4.2 and 34% DS.
Saccharification
enzyme OPTIMAX 4060 VIIP was added at 0.16 GAUs/g ds. The saccharification
was
carried at 60 C for 48-64 hours. At various time points, samples were taken
and the
composition of the reaction products were determined by the HPLC method (Table
2B).
As shown in Table 2B, glucose production reached approximately 95% in 48 hrs
for the
liquefact by Fuelzyme -LF / SPEZYME FRED Blend, 25/5 blend. The glucose
production level is similar to that achieved from the liquefact by Fuelzyme0-
LF in
Example 1.
Table 2B. High glucose syrup composition using liquefied starch from different
liquefying enzyme combinations.
Liquefying Enzymes DPs 5 hr
19 hr 29 hr 41 hr 48 hr 64 hr
DP1 52.52 90.41 93.45 94.78 94.97 95.30
Fuelzyme0-LF +
SPEZYME FRED Blend DP2 13.01 2.60 2.29 2.48 2.52 2.86
pH 5.6
DP3 3.90 2.88 1.86 1.69
1.15
[0193] The
saccharified starch was further evaluated by (1) iodine test, (2) sediment
test,
and (3) filtration test (as previously discussed), all of which are used to
evaluate the
51
CA 02771071 2012-02-06
WO 2011/017093 PCT/US2010/043369
potential of converting the saccharified starch (glucose syrup) to the high
fructose syrup
(HFCS or HFSS).
[0194] The saccharified starch (glucose syrup) was subject to iodine test for
both the
filtrate and the sediments. See FIG. 1. When stained with iodine, the sediment
from
saccharified starch originally liquefied with Fuelzyme -LF / SPEZYME FRED
Blend
25/5, turned yellow. This result indicated the absence of amylose complex
after
saccharification. The corresponding liquefact is of acceptable quality for
sweetener
applications. When the filtrate was subject to iodine test, the sample
developed a yellow
color giving similar results as in sediment iodine test. The saccharified
starch achieved
from Fuelzyme -LF / SPEZYME FRED blend was subject to the sediment test and
the
result is shown in Table 2C. The saccharified starch from the liquefact by
Fuelzyme -
LF/SPEZYME FRED blend 25/5 blend showed only 0.5% sediment, which is well
below the 1.5% industrial threshold and satisfactory for industrial usage.
[0195] The filtration result was also compatible with what was observed in
sediment test.
See Table 2C. The saccharified starch from the liquefact by Fuelzyme -LF /
SPEZYME FRED Blend exhibited the filtration rate improvement to 83 g/15 min,
which
is more than 2.5 times of the rates of the previous results from Fuelzyme -LF
in Example
1.
Table 2C. The blue saccharide, sediment, filtration and glucose results for
the
saccharification liquor from Fuelzyme -LF / SPEZYME FRED blend
Sediment Filter
Enzyme pH . Iodine Color
%g/15
Fuelzyme -LF +
SPEZYME FRED Blend 5.6 0.5 83 Neg/yellow
Example 3.
[0196] The starch slurry containing 38 % DS refined starch (Cargill,
Minneapolis, MN),
containing 10 ppm Ca2+, and 100 ppm sulfur dioxide (SO2) was prepared in a
metal bucket
with overnight stirring. The pH of the slurry was adjusted to pH 5.6 using
sodium
CA 02771071 2012-02-06
WO 2011/017093
PCT/US2010/043369
carbonate solution (20% w/v). The slurry Baume (degrees) was approximately
22.3. Four
sets of liquefactions were performed which included constant dose of Fuelzyme -
LF and
varying dose of SPEZYME FRED. The liquefaction was carried out as follows:
(1) Fuelzyme -LF at 25 MWIJs/g and SPEZYME FRED at 5 LUs/g;
(2) Fuelzyme -LF at 25 MWUs/g and SPEZYME FRED at 2.5 LUs/g;
(3) Fuelzyme -LF at 25 MWUs/g and SPEZYME FRED at 1 LUs/g; and
(4) Fuelzyme -LF at 25 MWUs/g
[0197] The slurry with the enzyme(s) added was sent through a pilot plant jet
cooker (Hydro-
thermal Corporation, Waukesha, WI) at 0.5 gpm with six-minute residence time
and
cooked at about 108-110 C for the primary cook. Secondary liquefaction was
performed
at 95 C for 120 minutes. The DE and refractive index (RI) were measured at
various time
points during the secondary liquefaction.
[0198] The data in Table 3A shows the DE development during the secondary
liquefaction.
The DE progressions were as expected through the enzyme dosages and were
highest for
the liquefaction 1 followed by liquefaction 2, liquefaction 3, and
liquefaction 4
respectively.
Table 3A. DE development for Fuelzyme -LF and SPEZYME FRED
Enzyme Treatment Time mm. D.E.
Fuelzyme -LF at 25 MWUs/g and 30 6.35
SPEZYME FRED at 5LI Ts/g 60 8.75
82 10.29
Fuelzyme -LF at 25 MWUs/g and 30 4.92
SPEZYME FRED at 2.5LUs/g 60 7.05
102 9.89
30 3.65
Fuelzyme -LF at 25 MWUs/g and 60 6.05
SPEZYME FRED at 1LUs/g 90 7.74
125 9.18
Fuelzyme -LF at 25 MWUs/g and 30 3.66
SPEZYME FRED at OLI Ts/g 60 5.74
53
CA 02771071 2012-02-06
WO 2011/017093
PCT/US2010/043369
90 7.34
132 8.79
[0199] The saccharification performances were similar for all the treatment
with glucose
levels reaching ¨94-95% in 48 hrs (Table 3B).
Table 3B. High glucose syrup composition using liquefied starch from different
liquefying enzyme combinations.
Enzyme Treatment Hour DP1 DP2 DP3
Fuelzyme -LF at 25 MWUs/g and 24 90.109 2.939 4.609
SPEZYME FRED at 5LUs/g 48 94.091 2.468 2.481
Fuelzyme -LF at 25 MWUs/g and 74 90.596 2.731 6.672
SPEZYME FRED at 2.5LUs/g 48 94.19 2.475 2.572
Fuelzyme -LF at 25 MWUs/g and 24 91.121 2.513 3.763
SPEZYME FRED at 1LUs/g 48 94.55 2.504 1.942
Fuelzyme -LF at 25 MWUs/g and 24 91.38 2.482 3.939
SPEZYME FRED at Of ,Us/g 48 94.515 2.518 1.98
[0200] The saccharified starch was further evaluated by (1) iodine test, (2)
sediment test,
and (3) filtration test (as previously discussed), all of which are used to
evaluate the
potential of converting the saccharified starch (glucose syrup) to the high
fructose syrup
(HFCS or HFSS).
[0201] Only the saccharification liquor from liquefaction 1 (Blend of Fuelzyme
-LF at 25
MWUs/g and SPEZYME FRED at 5 LUs/g) was iodine negative, while all other
three
treatments were blue/green when stained with iodine. The tubes were left
standing for 24
and results were found still similar.
[0202] The results from sediment test of the saccharification liquor shows
that the blend of
Fuelzyme -LF at 25 MWUs/g and SPEZYME FRED at 5 LUs/g had lowest (<3%)
sediments. Sediments for Fuelzyme -LF at 25 MWUs/g with no SPEZYME FRED
were the highest at 15%. Higher sediments are unacceptable as it may plug up
the
filtration and reduce the output in sweeteners applications.
54
CA 02771071 2012-02-06
WO 2011/017093
PCT/US2010/043369
Table 3C. The blue saccharide, sediment, filtration and glucose results for
the
saccharification liquor from Fuelzyme -LF and SPEZYME FRED liquefact.
Sediment Filter g/15
Enzyme Treatment Iodine Color
min
Fuelzyme -LF at 25 MWUs/g and
<3 87.71 Neg/yellovv
SPEZYME0 FRED at 5 LUs/g
Fuelzyme -LF at 25 MWUs/g and
3 90.7 Greenish
SPEZYMEO FRED at 2.5 LUs/g
Fuelzyme -LF at 25 MWUs/g and
6 21.14 Blue
SPEZYMEO FRED at 1 LUs/g
Fuelzyme -LF at 25 MWUs/g and
15 11.22 Blue
SPEZYMEO FRED at 0 LUs/g
CA 02771071 2012-02-06
WO 2011/017093
PCT/US2010/043369
SEQUENCE LISTING
SEQ ID NO: 1: DNA sequence of Fuelzyme LF (AF504065; SEQ ID NO: 1 of U.S.
Patent
No. 7,273,740)
1 ATCCCCAACT ACTCCCACCT CCAAAACCCC CCCCTCATAA TCCACCCCTT
51 CTACTGGGAC GTGCCTTCAG GAGGAATATC GTGGCACACA ATACGGCAGA
101 AGATACCGGA GTCGTACGAT GCCGCAATCT CCGCAATATG GATTCCOCCC
151 GCGAGCAAGG GCATGGGCGG CGCCTATTCG ATGGGCTACG ACCCCTACGA
201 CTTCTTTGAC CTCGGTGAGT ACGACCAGAA GGGAACGGTA GAGACGCGCT
251 TTGGCTCCAA GCAGGAGCTC GTGAACATGA TAAACACCGC CCACGCCTAT
301 GGCATGAAGG TAATAGCCGA TATAGTCATC AACCACCGCG CCGGCGGTGA
351 CCTCCACTCC AACCCCTTCC TCAACCACTA TACCTCCACC CACTTCTCAA
401 AGGTCGCGTC GGGTAAATAC ACGGCCAACT ACCTCGACTT CCACCCGAAC
451 GAGCTCCATG CGGGCGATTC CCGAACATIT GGAGGCTATC CCGACATATG
501 CCACGACAAG AGCTGGGACC AGTACTGGCT CTGGGCCAGC CAGGAGAGCT
551 ACGCGGCATA TCTCAGGAGC ATCGGCATCG ATGCCTGGCG CTTCGACTAC
601 GTCAAGGGCT ATGCTCCCTG GGTCGTCAAG GACTGGCTGA ACTGGTGGGG
650 AGGCTGGGCG GTTGGAGAGT ACTGGGACAC CAACGTCGAC GCTGTTCTCA
701 ACTGGGCATA CTCGAGCGGT GCCAAGGTCT TTGACTTCGC CCTCTACTAC
751 AAGATGGATG AGGCCTTTGA CAACAAAAAC ATTCCAGCGC TCGTCTCTGC
801 CCTTCAGAAC GGCCAGACTG TTGTCTCCCG CGACCCGTTC AAGGCCGTAA
851 CCTTTGTAGC AAACCACGAC ACCGATATAA TCTGCAACAA GTATCCAGCC
901 TACGCGTTCA TCCTCACCTA CCAGGGCCAG CCGACAATAT TCTACCGCGA
951 CTACGAGGAG TGGCTCAACA AGGATAAGCT CAAGAACCTC ATCTGGATAC
1001 ATGAGAACCT CGCCGGAGGA AGCACCGACA TAGTCTACTA CGATAACGAT
1051 GAACTCATCT TCGTCAGGAA CGGCTACGGG GACAAGCCGG GGCTTATAAC
1101 CTACATCAAC CTACCCTCCA CCAACCCCCC AACCTCCCTT TATCTCCCCA
1151 AGTTCGCGGG CGCGTGCATC CACCAGTATA CTGGTAACCT CGGAGGCTGG
1201 GTAGACAAGT ACGTCTACTC AAGCCGCTGC GTCTATCTCG AAGCTCCAGC
1251 TTACGACCCT GCCAACGGGC AGTATGGCTA CTCCGTGTGG AGCTACTGCG
1301 GGGTGGGCTG A
SEQ ID NO: 2: synthetic construct for alpha-amylase, Ultra-Thin or Fuelzyme-LF
(AAM48115; SEQ ID NO: 2 of U.S. Patent No. 7,273,740)
1 MAKYSELEKG GVIMQAFYWD VPSGGIWWDT IRQKIPEWYD AGISAIWIPP
51 ASKGMGGAYS MGYDPYDFFD LGEYDQKGTV ETREGSKQEL VNMINTAHAY
101 GMKVIADIVI NHRAGGDLEW NPFVNDYTWT DFSKVASGKY TANYLDFHPN
151 ELHAGDSGTF GGYPDICHDK SWDQYWLWAS QESYAAYLRS IGIDAWRFDY
201 VKCYAPWVVK DWLNWWCCWA VCEYWDTNVC AVLNWAYSSC AKVFDFALYY
251 KMDEAFDNKN IPALVSALQN GQTVVSRDPF KAVTFVANHD TDIIWNKYPA
301 YAFILTYECQ PTIFYRDYEE WLNKDKLKNL IWIHENLACC STDIVYYDND
351 ELIFVRNGYG DKPGLITYIN LGSSKAGRWV YVPKFAGACI HEYTGNLGGW
401 VDKYVYSSGW VYLEAPAYDP ANGQYGYSVW SYCGVG
56
CA 02771071 2012-02-06
WO 2011/017093
PCT/US2010/043369
SEQ ID NO: 3: Wild-type LAT DNA (SEQ ID NO: 3 of U.S.S.N. 12/263,804, filed
Nov. 3,
2008)
atgaaacaac aaaaacggct ttacgcccga ttgctgacgc tgttatttgc
gctcatcttc ttgctgcctc attctgcagc ttcagcagca aatcttaatg
ggacgctgat gcagtatttt gaatggtaca tgcccaatga cggccaacat
tggaagcgtt tgcaaaacga ctcggcatat ttggctgaac acggtattac
tgccgtctgg attcccccgg catataaggg aacgagccaa gcggatgtgg
gctacggtgc ttacgacctt tatgatttag gggagtttca tcaaaaaggg
acggttcgga caaagtacgg cacaaaagga gagctgcaat ctgcgatcaa
aagtcttcat tcccgcgaca ttaacgttta cggggatgtg gtcatcaacc
acaaaggcgg cgctgatgcg accgaagatg taaccgcggt tgaagtcgat
cccgctgacc gcaaccgcgt aatttcagga gaacacctaa ttaaagcctg
gacacatttt cattttccgg ggcgcggcag cacatacagc gattttaaat
ggcattggta ccattttgac ggaaccgatt gggacgagtc ccgaaagctg
aaccgcatct ataagtttca aggaaaggct tgggattggg aagtttccaa
tgaaaacggc aactatgatt atttgatgta tgccgacatc gattatgacc
atcctgatgt cgcagcagaa attaagagat ggggcacttg gtatgccaat
gaactgcaat tggacggttt ccgtcttgat gctgtcaaac acattaaatt
ttcttttttg cgggattggg ttaatcatgt cagggaaaaa acggggaagg
aaatgtttac ggtagctgaa tattggcaga atgacttggg cgcgctggaa
aactatttga acaaaacaaa ttttaatcat tcagtgtttg acgtgccgct
tcattatcag ttccatgctg catcgacaca gggaggcggc tatgatatga
ggaaattgct gaacggtacg gtcgtttcca agcatccgtt gaaatcggtt
acatttgtcg ataaccatga tacacagccg gggcaatcgc ttgagtcgac
tgtccaaaca tggtttaagc cgcttgctta cgcttttatt ctcacaaggg
aatctggata ccctcaggtt ttctacgggg atatgtacgg gacgaaagga
gactcccagc gcgaaattcc tgccttgaaa cacaaaattg aaccgatctt
aaaagcgaga aaacagtatg cgtacggagc acagcatgat tatttcgacc
accatgacat tgtcggctgg acaagggaag gcgacagctc ggttgcaaat
tcaggtttgg cggcattaat aacagacgga cccggtgggg caaagcgaat
gtatgtcggc cggcaaaacg ccggtgagac atggcatgac attaccggaa
accgttcgga gccggttgtc atcaattcgg aaggctgggg agagtttcac
gtaaacggcg ggtcggtttc aatttatgtt caaaga
SEQ ID NO: 4: Wild-type LA l' polypeptide (SEQ Ill NO: 4 of U.S.S.N.
12/263,804, filed
Nov. 3, 2008)
ANLNGTLMQY FEWYMPNDGQ HWKRLQNDSA YLAEHGITAV WIPPAYKGTS
QADVGYGAYD LYDLGEFHQK GIVRTKYGTK GELQSAIKSL HSRDINVYGD
VVINEKGGAD ATEDVTAVEV DPADRNRVIS GEHLIKAWTH FEEPGRGSTY
SDFKWHWYHF DGTDWDESRK LNRIYKFQGK AWCWEVSNEN GNYDYLMYAD
IDYDHPDVAA EIKRWGTWYA NELQLDGFRL DAVKHIKFSF LRDWVNHVRE
KTGKEMFTVA EYWQNDLGAL ENYLNKTNFN HSVFDVPLHY QFHAASTQGG
GYDMRKLLNG TVVSKHPLKS VTFVDNHDTQ PGQSLESTVQ TWFKPLAYAF
ILTRESGYPQ VFYGDMYGTK GDSQREIPAL KHKIEPILKA RKQYAYGAQH
DYFDHEDIVG WTREGDSSVA NSGLAALITD GPGGAKRMYV GRQNAGETWH
DITGNRSEPV VINSEGWGEE HVNGGSVSIY VQR
57
CA 02771071 2012-02-06
WO 2011/017093
PCT/US2010/043369
SEQ ID NO: 5: DNA sequence of FRED
AGCTTGAAGAAGTGAAGAAGGAGAGAGGCTATTGAATAAATGAGTAGAAAGCGCCATATCGG
CGCTTTTCTTTTGGAAGAAAATATAGGGAAAATGGTACTTGTTAAAAATTCGGAATATTTAT
ACAACATCATATGTTTCACATTGAAACGOCAGGAGAATCATGAAACAACAAAAACCGCTTTA
CGCCCGATTGCTGACGCTGTTATTTGCGCTCATCTTCTTGCTGCCTCATTCTGCAGCAGCGG
CGGCAAATCTTAATGGGACGCTGATGCAGTATITTCAATGGTACATGCCCAATGACGGCCAA
CATTGGAAGCGTTTGCAAAACGACTCCGCATATTTGGCTGAACACGGTATTACTGCCGTCTG
GATTCCCCCGGCATATAAGGGAACGAGCCAAGCGGATGTGGGCTACGGTGCTTACGACCTTT
ATGATTTAGGGGAGTTTCATCAAAAAGGGACGGTTCGGACAAAGTACGGCACAAAAGGAGAG
CTGCAATCTGCGATCAAAAGICTICATTCCCGCGACATTAACGTTTACGGGGATGTGGTCAT
CAACCACAAACCCCCCCCTCATCCCACCCAACATCTAACCCCCCTTCAACTCCATCCCCCTC
ACCCCAACCGCGTAATTICAGGAGAACACCTAATTAAAGCCTGGACACATTTTCATTTTCCG
GGGCGCGGCAGCACATACAGCGATTTTAAATGCCATTGGTACCATTTTGACGGAACCGATTG
GGACGAGTCCCGAAAGCTGAACCGCATCTATAAGTTTCAAGGAAAGGCTTGGGATTGGGAAG
TTTCCAATGAAAACGGCAACTATGATTATTTGATGTATGCCGACATCGATTATGACCATCCT
GATGTCGCAGGAGAAATTAAGAGATGGGGCACTTGGTATGCCAATGAACTGCAATTGGACGG
TTTCCGTCTTGATGCTGTCAAACACATTAAATTTTCTTTTTTGCGGGATTGGGTTAATCATG
TCAGGGAAAAAACGGGGAAGGAAATGITTACGGTAGCTGAATATTGGCAGAATGACTTGGGC
GCGCTCGAAAACTATTTGAACAAAACAAATTTTAATCATTCAGTGTTTGACGTGCCGCTTCA
TTATCAGTTCCATGCTGCATCGACACAGGCAGCCGCCTATGATATGAGGAAATTGCTGAACG
GTACGGTCGTTTCCAAGCATCCGTTGAAATCGCTTACATTTCTCGATAACCATGATACACAG
CCGGGGCAATCGCTTGAGTCGACTGTCCAAACATGGTTTAAGCCGCTTGCTTACGCTTTTAT
TCTCACAAGGGAATCTGGATACCCTCAGGTTTTCTACGGGGATATGTACGGGACGAAAGGAG
ACTCCCAGCGCGAAATTCCTGCCTTGAAACACAAAATTGAACCGATCTTAAAAGCGAGAAAA
CAGTATGCGTACGGAGCACAGCATGATTATTTCGACCACCATGACATTGTCGGCTGGACAAG
CCAACCCCACACCTCGCTTCCAAATTCACCTTICGCGGCATTAATAACACACCCACCCCGTC
CGOCAAAGCGAATGTATOTCGOCCGGCAAAACGCCGGTGAGACATGGCATGACATTACCOGA
AACCGTTCGGAGCCGGTTGTCATCAATTCCGAAGGCTGGGGAGAGTTTCACGTAAACGGCGG
GTCGGTTTCAATTTATGITCAAAGATAGAAGACCAGAGAGGACGGATTTCCTGAAGGAAATC
CGTTTTTTTATTTTGCCCGTCTTATAAATTTCTTTGATTACATTTTATAATTAATTTTAACA
AAGTGTCATCAGCCCTCAGGAAGGACTTGCTGACAGTTTGAATCGCATAGGTAAGGCGGGGA
TGAAATGGCAACGTTATCTGATGTAGCAAAGAAAGCAAATGTGTCGAAAATGACGGTATCGC
GGGTGATCAATCATCCTGAGACTGTGACGGATGAATTGAAAAAGCT
SEQ ID NO: 6: SPEZYMECTRED alpha-amylase amino acid sequence.
1 MKQQKRLYAR LLTLLFALIF LLPHSAAAAA NLNCTLMQYF EWYTPNDGQH
51 WKRLQNDSAY LAEHGITAVW IPPAYKGTSQ ADVGYGAYDL YDLGEFHQKG
101 TVRTKYGTKG ELQSAIKSLH SRDINVYGDV VINHKGGADA TEDVTAVEVD
151 PADRNRVISG EYLIKAWTHF HFPGRCSTYS DEKWHWYEED GTDWDESRKL
201 NRIYKFQGKA WDWEVSSENG NYDYLMYACI CYDHPDVVAE IKRWGTWYAN
251 ELQLDGFRLD AVKHIKFSFL RDWVNHVREK TGKEMFTVAE YWQNDLGALE
301 NYLNKTNFNH SVFDVPLHYQ FHAASTQGGG YDMRKLLNGT VVSKHPLKSV
351 TFVDNEDTQP GQSLESTVQT WFKPLAYAFI LTRESGYPQV FYGDMYGTKG
401 DSQREIPALK HKIEPILKAR KQYAYGAQHD YFDHHDIVGW TREGDSSVAN
451 SGLAALITDG PGGAKRMYVG RQNAGETWHD ITGNRSEPVV INSEGWGEFH
58
CA 02771071 2012-02-06
WO 2011/017093
PCT/US2010/043369
501 VNGCSVS I YV QR
59
